<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="http://www.fda.gov/oc/datacouncil/stylesheets/spl/spl.xsl" type="text/xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 http://www.fda.gov/oc/datacouncil/schemas/spl/spl.xsd">
<id root="6C5772D3-FB26-EA0B-4F96-8002671D8166" />
<code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABELING" />
<effectiveTime value="20080519" />
<setId root="649d285c-8fcb-48dd-aa5e-2f34128102f5" />
<versionNumber value="1" />
<author>
<time />
<assignedEntity>
<representedOrganization>
<name>Ranbaxy Pharmaceutical Inc.</name>
</representedOrganization>
</assignedEntity>
</author>
<component>
<structuredBody>
<component>
<section>
<id root="A67002F2-7B41-E548-64C2-00E7F89C0B09" />
<effectiveTime value="20080519" />
<subject>
<manufacturedProduct>
<manufacturedMedicine>
<code code="63304-654" codeSystem="2.16.840.1.113883.6.69" />
<name>AMOXICILLIN</name>
<formCode code="C25158" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CAPSULE" />
<activeIngredient>
<quantity>
<numerator unit="mg" value="250">
<translation code="C28253" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLIGRAM" value="250" />
</numerator>
<denominator unit="1" value="1">
<translation code="C48480" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CAPSULE" value="1" />
</denominator>
</quantity>
<activeIngredientSubstance>
<code code="804826J2HU" codeSystem="2.16.840.1.113883.4.9" displayName="AMOXICILLIN" />
<name>amoxicillin</name>
<activeMoiety>
<activeMoiety>
<code code="804826J2HU" codeSystem="2.16.840.1.113883.4.9" displayName="AMOXICILLIN" />
<name>amoxicillin</name>
</activeMoiety>
</activeMoiety>
</activeIngredientSubstance>
</activeIngredient>
<asEntityWithGeneric>
<genericMedicine>
<name>Amoxicillin</name>
</genericMedicine>
</asEntityWithGeneric>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>black iron oxide</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>colloidal silicon dioxide</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>croscarmellose sodium</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>D&amp;C yellow no. 10</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>FD&amp;C red no. 40</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>FD&amp;C yellow no. 6</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="2G86QN327L" codeSystem="2.16.840.1.113883.4.9" />
<name>gelatin</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="70097M6I30" codeSystem="2.16.840.1.113883.4.9" />
<name>magnesium stearate</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>microcrystalline cellulose</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>shellac</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="368GB5141J" codeSystem="2.16.840.1.113883.4.9" />
<name>sodium lauryl sulfate</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="15FIX9V2JP" codeSystem="2.16.840.1.113883.4.9" />
<name>titanium dioxide</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<asContent>
<quantity>
<numerator unit="1" value="20">
<translation code="C48480" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CAPSULE" value="20" />
</numerator>
<denominator value="1">
<translation codeSystem="2.16.840.1.113883.3.26.1.1" value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-654-20" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="30">
<translation code="C48480" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CAPSULE" value="30" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-654-30" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="100">
<translation code="C48480" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CAPSULE" value="100" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-654-01" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="500">
<translation code="C48480" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CAPSULE" value="500" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-654-05" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="10">
<translation code="C48480" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CAPSULE" value="10" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-654-11" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43168" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLISTER PACK" />
<asContent>
<quantity>
<numerator unit="1" value="10">
<translation code="C61569" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLISTER PACK" value="10" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-654-77" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON" />
</containerPackagedMedicine>
</asContent>
</containerPackagedMedicine>
</asContent>
</manufacturedMedicine>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLCOATING" codeSystem="2.16.840.1.113883.1.11.19255" />
<value value="false" xsi:type="BL" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLCOLOR" codeSystem="2.16.840.1.113883.1.11.19255" />
<value code="C48330" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="yellow" xsi:type="CE"><originalText>yellow opaque</originalText></value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLIMPRINT" codeSystem="2.16.840.1.113883.1.11.19255" />
<value xsi:type="ST">RX;654</value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSCORE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value nullFlavor="OTH" xsi:type="PQ" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSHAPE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value code="C48336" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CAPSULE" xsi:type="CE"><originalText /></value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSIZE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value unit="mm" value="18" xsi:type="PQ" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSYMBOL" codeSystem="2.16.840.1.113883.1.11.19255" />
<value value="false" xsi:type="BL" />
</characteristic>
</subjectOf>
<consumedIn>
<substanceAdministration>
<routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ORAL" />
</substanceAdministration>
</consumedIn>
</manufacturedProduct>
</subject>
<subject>
<manufacturedProduct>
<manufacturedMedicine>
<code code="63304-655" codeSystem="2.16.840.1.113883.6.69" />
<name>AMOXICILLIN</name>
<formCode code="C25158" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CAPSULE" />
<activeIngredient>
<quantity>
<numerator unit="mg" value="500">
<translation code="C28253" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLIGRAM" value="500" />
</numerator>
<denominator unit="1" value="1">
<translation code="C48480" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CAPSULE" value="1" />
</denominator>
</quantity>
<activeIngredientSubstance>
<code code="804826J2HU" codeSystem="2.16.840.1.113883.4.9" displayName="AMOXICILLIN" />
<name>amoxicillin</name>
<activeMoiety>
<activeMoiety>
<code code="804826J2HU" codeSystem="2.16.840.1.113883.4.9" displayName="AMOXICILLIN" />
<name>amoxicillin</name>
</activeMoiety>
</activeMoiety>
</activeIngredientSubstance>
</activeIngredient>
<asEntityWithGeneric>
<genericMedicine>
<name>Amoxicillin</name>
</genericMedicine>
</asEntityWithGeneric>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>black iron oxide</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>colloidal silicon dioxide</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>croscarmellose sodium</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>D&amp;C red no. 28</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>D&amp;C yellow no. 10</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>FD&amp;C blue no. 1</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>FD&amp;C yellow no. 6</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="2G86QN327L" codeSystem="2.16.840.1.113883.4.9" />
<name>gelatin</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="70097M6I30" codeSystem="2.16.840.1.113883.4.9" />
<name>magnesium stearate</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>microcrystalline cellulose</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>shellac</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="368GB5141J" codeSystem="2.16.840.1.113883.4.9" />
<name>sodium lauryl sulfate</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="15FIX9V2JP" codeSystem="2.16.840.1.113883.4.9" />
<name>titanium dioxide</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<asContent>
<quantity>
<numerator unit="1" value="20">
<translation code="C48480" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CAPSULE" value="20" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-655-20" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="30">
<translation code="C48480" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CAPSULE" value="30" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-655-30" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="40">
<translation code="C48480" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CAPSULE" value="40" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-655-40" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="50">
<translation code="C48480" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CAPSULE" value="50" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-655-50" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="100">
<translation code="C48480" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CAPSULE" value="100" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-655-01" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="500">
<translation code="C48480" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CAPSULE" value="500" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-655-05" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="10">
<translation code="C48480" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CAPSULE" value="10" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-655-11" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43168" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLISTER PACK" />
<asContent>
<quantity>
<numerator unit="1" value="10">
<translation code="C61569" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BLISTER PACK" value="10" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-655-77" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON" />
</containerPackagedMedicine>
</asContent>
</containerPackagedMedicine>
</asContent>
</manufacturedMedicine>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLCOATING" codeSystem="2.16.840.1.113883.1.11.19255" />
<value value="false" xsi:type="BL" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLCOLOR" codeSystem="2.16.840.1.113883.1.11.19255" />
<value code="C48330" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="yellow" xsi:type="CE"><originalText>yellow opaque</originalText></value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLCOLOR" codeSystem="2.16.840.1.113883.1.11.19255" />
<value code="C48326" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="red" xsi:type="CE"><originalText>maroon opaque</originalText></value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLIMPRINT" codeSystem="2.16.840.1.113883.1.11.19255" />
<value xsi:type="ST">RX;655</value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSCORE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value nullFlavor="OTH" xsi:type="PQ" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSHAPE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value code="C48336" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CAPSULE" xsi:type="CE"><originalText /></value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSIZE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value unit="mm" value="23" xsi:type="PQ" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSYMBOL" codeSystem="2.16.840.1.113883.1.11.19255" />
<value value="false" xsi:type="BL" />
</characteristic>
</subjectOf>
<consumedIn>
<substanceAdministration>
<routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ORAL" />
</substanceAdministration>
</consumedIn>
</manufacturedProduct>
</subject>
<subject>
<manufacturedProduct>
<manufacturedMedicine>
<code code="63304-762" codeSystem="2.16.840.1.113883.6.69" />
<name>AMOXICILLIN</name>
<formCode code="C42931" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET, FILM COATED" />
<activeIngredient>
<quantity>
<numerator unit="mg" value="500">
<translation code="C28253" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLIGRAM" value="500" />
</numerator>
<denominator unit="1" value="1">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="1" />
</denominator>
</quantity>
<activeIngredientSubstance>
<code code="804826J2HU" codeSystem="2.16.840.1.113883.4.9" displayName="AMOXICILLIN" />
<name>amoxicillin</name>
<activeMoiety>
<activeMoiety>
<code code="804826J2HU" codeSystem="2.16.840.1.113883.4.9" displayName="AMOXICILLIN" />
<name>amoxicillin</name>
</activeMoiety>
</activeMoiety>
</activeIngredientSubstance>
</activeIngredient>
<asEntityWithGeneric>
<genericMedicine>
<name>Amoxicillin</name>
</genericMedicine>
</asEntityWithGeneric>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>colloidal silicon dioxide</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>crospovidone</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>D&amp;C red no. 30 aluminum lakes</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>hypromellose</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="70097M6I30" codeSystem="2.16.840.1.113883.4.9" />
<name>magnesium stearate</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>microcrystalline cellulose</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>polyethylene glycol</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>sodium starch glycolate</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="15FIX9V2JP" codeSystem="2.16.840.1.113883.4.9" />
<name>titanium dioxide</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<asContent>
<quantity>
<numerator unit="1" value="12">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="12" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-762-82" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="20">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="20" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-762-20" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="100">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="100" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-762-01" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="120">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="120" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-762-13" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="500">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="500" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-762-05" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
</manufacturedMedicine>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLCOATING" codeSystem="2.16.840.1.113883.1.11.19255" />
<value value="true" xsi:type="BL" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLCOLOR" codeSystem="2.16.840.1.113883.1.11.19255" />
<value code="C48328" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="pink" xsi:type="CE"><originalText /></value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLIMPRINT" codeSystem="2.16.840.1.113883.1.11.19255" />
<value xsi:type="ST">RX762</value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSCORE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value nullFlavor="OTH" xsi:type="PQ" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSHAPE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value code="C48345" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="OVAL" xsi:type="CE"><originalText>capsule-shaped</originalText></value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSIZE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value unit="mm" value="18" xsi:type="PQ" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSYMBOL" codeSystem="2.16.840.1.113883.1.11.19255" />
<value value="false" xsi:type="BL" />
</characteristic>
</subjectOf>
<consumedIn>
<substanceAdministration>
<routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ORAL" />
</substanceAdministration>
</consumedIn>
</manufacturedProduct>
</subject>
<subject>
<manufacturedProduct>
<manufacturedMedicine>
<code code="63304-763" codeSystem="2.16.840.1.113883.6.69" />
<name>AMOXICILLIN</name>
<formCode code="C42931" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET, FILM COATED" />
<activeIngredient>
<quantity>
<numerator unit="mg" value="875">
<translation code="C28253" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLIGRAM" value="875" />
</numerator>
<denominator unit="1" value="1">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="1" />
</denominator>
</quantity>
<activeIngredientSubstance>
<code code="804826J2HU" codeSystem="2.16.840.1.113883.4.9" displayName="AMOXICILLIN" />
<name>amoxicillin</name>
<activeMoiety>
<activeMoiety>
<code code="804826J2HU" codeSystem="2.16.840.1.113883.4.9" displayName="AMOXICILLIN" />
<name>amoxicillin</name>
</activeMoiety>
</activeMoiety>
</activeIngredientSubstance>
</activeIngredient>
<asEntityWithGeneric>
<genericMedicine>
<name>Amoxicillin</name>
</genericMedicine>
</asEntityWithGeneric>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>colloidal silicon dioxide</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>crospovidone</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>D&amp;C red no. 30 aluminum lakes</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>hypromellose</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="70097M6I30" codeSystem="2.16.840.1.113883.4.9" />
<name>magnesium stearate</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>microcrystalline cellulose</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>polyethylene glycol</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>sodium starch glycolate</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="15FIX9V2JP" codeSystem="2.16.840.1.113883.4.9" />
<name>titanium dioxide</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<asContent>
<quantity>
<numerator unit="1" value="12">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="12" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-763-82" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="20">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="20" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-763-20" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="100">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="100" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-763-01" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="120">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="120" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-763-13" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="500">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="500" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-763-05" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
</manufacturedMedicine>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLCOATING" codeSystem="2.16.840.1.113883.1.11.19255" />
<value value="true" xsi:type="BL" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLCOLOR" codeSystem="2.16.840.1.113883.1.11.19255" />
<value code="C48328" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="pink" xsi:type="CE"><originalText /></value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLIMPRINT" codeSystem="2.16.840.1.113883.1.11.19255" />
<value xsi:type="ST">RX763</value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSCORE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value value="1" xsi:type="INT" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSHAPE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value code="C48345" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="OVAL" xsi:type="CE"><originalText>capsule-shaped</originalText></value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSIZE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value unit="mm" value="21" xsi:type="PQ" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSYMBOL" codeSystem="2.16.840.1.113883.1.11.19255" />
<value value="false" xsi:type="BL" />
</characteristic>
</subjectOf>
<consumedIn>
<substanceAdministration>
<routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ORAL" />
</substanceAdministration>
</consumedIn>
</manufacturedProduct>
</subject>
<subject>
<manufacturedProduct>
<manufacturedMedicine>
<code code="63304-514" codeSystem="2.16.840.1.113883.6.69" />
<name>AMOXICILLIN</name>
<formCode code="C42893" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET, CHEWABLE" />
<activeIngredient>
<quantity>
<numerator unit="mg" value="125">
<translation code="C28253" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLIGRAM" value="125" />
</numerator>
<denominator unit="1" value="1">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="1" />
</denominator>
</quantity>
<activeIngredientSubstance>
<code code="804826J2HU" codeSystem="2.16.840.1.113883.4.9" displayName="AMOXICILLIN" />
<name>amoxicillin</name>
<activeMoiety>
<activeMoiety>
<code code="804826J2HU" codeSystem="2.16.840.1.113883.4.9" displayName="AMOXICILLIN" />
<name>amoxicillin</name>
</activeMoiety>
</activeMoiety>
</activeIngredientSubstance>
</activeIngredient>
<asEntityWithGeneric>
<genericMedicine>
<name>Amoxicillin</name>
</genericMedicine>
</asEntityWithGeneric>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="Z0H242BBR1" codeSystem="2.16.840.1.113883.4.9" />
<name>aspartame</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>compressible sugar</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>corn starch</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>FD&amp;C red no. 40 aluminum lakes</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="70097M6I30" codeSystem="2.16.840.1.113883.4.9" />
<name>magnesium stearate</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9" />
<name>mannitol</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>strawberry guarana flavor</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="7SEV7J4R1U" codeSystem="2.16.840.1.113883.4.9" />
<name>talc</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<asContent>
<quantity>
<numerator unit="1" value="100">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="100" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-514-01" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="500">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="500" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-514-05" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
</manufacturedMedicine>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLCOATING" codeSystem="2.16.840.1.113883.1.11.19255" />
<value value="false" xsi:type="BL" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLCOLOR" codeSystem="2.16.840.1.113883.1.11.19255" />
<value code="C48328" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="pink" xsi:type="CE"><originalText /></value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLIMPRINT" codeSystem="2.16.840.1.113883.1.11.19255" />
<value xsi:type="ST">RX514</value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSCORE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value nullFlavor="OTH" xsi:type="PQ" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSHAPE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value code="C48345" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="OVAL" xsi:type="CE"><originalText>oval</originalText></value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSIZE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value unit="mm" value="16" xsi:type="PQ" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSYMBOL" codeSystem="2.16.840.1.113883.1.11.19255" />
<value value="false" xsi:type="BL" />
</characteristic>
</subjectOf>
<consumedIn>
<substanceAdministration>
<routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ORAL" />
</substanceAdministration>
</consumedIn>
</manufacturedProduct>
</subject>
<subject>
<manufacturedProduct>
<manufacturedMedicine>
<code code="63304-760" codeSystem="2.16.840.1.113883.6.69" />
<name>AMOXICILLIN</name>
<formCode code="C42893" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET, CHEWABLE" />
<activeIngredient>
<quantity>
<numerator unit="mg" value="200">
<translation code="C28253" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLIGRAM" value="200" />
</numerator>
<denominator unit="1" value="1">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="1" />
</denominator>
</quantity>
<activeIngredientSubstance>
<code code="804826J2HU" codeSystem="2.16.840.1.113883.4.9" displayName="AMOXICILLIN" />
<name>amoxicillin</name>
<activeMoiety>
<activeMoiety>
<code code="804826J2HU" codeSystem="2.16.840.1.113883.4.9" displayName="AMOXICILLIN" />
<name>amoxicillin</name>
</activeMoiety>
</activeMoiety>
</activeIngredientSubstance>
</activeIngredient>
<asEntityWithGeneric>
<genericMedicine>
<name>Amoxicillin</name>
</genericMedicine>
</asEntityWithGeneric>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="Z0H242BBR1" codeSystem="2.16.840.1.113883.4.9" />
<name>aspartame</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>crospovidone</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>FD&amp;C red no. 40 aluminum lakes</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="70097M6I30" codeSystem="2.16.840.1.113883.4.9" />
<name>magnesium stearate</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9" />
<name>mannitol</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>strawberry guarana flavor</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<asContent>
<quantity>
<numerator unit="1" value="20">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="20" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-760-20" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="100">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="100" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-760-01" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="500">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="500" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-760-05" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
</manufacturedMedicine>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLCOATING" codeSystem="2.16.840.1.113883.1.11.19255" />
<value value="false" xsi:type="BL" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLCOLOR" codeSystem="2.16.840.1.113883.1.11.19255" />
<value code="C48328" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="pink" xsi:type="CE"><originalText>light pink</originalText></value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLIMPRINT" codeSystem="2.16.840.1.113883.1.11.19255" />
<value xsi:type="ST">RX760</value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSCORE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value nullFlavor="OTH" xsi:type="PQ" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSHAPE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value code="C48348" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ROUND" xsi:type="CE"><originalText>circular</originalText></value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSIZE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value unit="mm" value="11" xsi:type="PQ" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSYMBOL" codeSystem="2.16.840.1.113883.1.11.19255" />
<value value="false" xsi:type="BL" />
</characteristic>
</subjectOf>
<consumedIn>
<substanceAdministration>
<routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ORAL" />
</substanceAdministration>
</consumedIn>
</manufacturedProduct>
</subject>
<subject>
<manufacturedProduct>
<manufacturedMedicine>
<code code="63304-515" codeSystem="2.16.840.1.113883.6.69" />
<name>AMOXICILLIN</name>
<formCode code="C42893" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET, CHEWABLE" />
<activeIngredient>
<quantity>
<numerator unit="mg" value="250">
<translation code="C28253" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLIGRAM" value="250" />
</numerator>
<denominator unit="1" value="1">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="1" />
</denominator>
</quantity>
<activeIngredientSubstance>
<code code="804826J2HU" codeSystem="2.16.840.1.113883.4.9" displayName="AMOXICILLIN" />
<name>amoxicillin</name>
<activeMoiety>
<activeMoiety>
<code code="804826J2HU" codeSystem="2.16.840.1.113883.4.9" displayName="AMOXICILLIN" />
<name>amoxicillin</name>
</activeMoiety>
</activeMoiety>
</activeIngredientSubstance>
</activeIngredient>
<asEntityWithGeneric>
<genericMedicine>
<name>Amoxicillin</name>
</genericMedicine>
</asEntityWithGeneric>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="Z0H242BBR1" codeSystem="2.16.840.1.113883.4.9" />
<name>aspartame</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>compressible sugar</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>corn starch</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>FD&amp;C red no. 40 aluminum lakes</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="70097M6I30" codeSystem="2.16.840.1.113883.4.9" />
<name>magnesium stearate</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9" />
<name>mannitol</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>strawberry guarana flavor</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="7SEV7J4R1U" codeSystem="2.16.840.1.113883.4.9" />
<name>talc</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<asContent>
<quantity>
<numerator unit="1" value="30">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="30" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-515-30" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="100">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="100" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-515-01" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="250">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="250" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-515-04" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
</manufacturedMedicine>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLCOATING" codeSystem="2.16.840.1.113883.1.11.19255" />
<value value="false" xsi:type="BL" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLCOLOR" codeSystem="2.16.840.1.113883.1.11.19255" />
<value code="C48328" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="pink" xsi:type="CE"><originalText /></value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLIMPRINT" codeSystem="2.16.840.1.113883.1.11.19255" />
<value xsi:type="ST">RX515</value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSCORE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value nullFlavor="OTH" xsi:type="PQ" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSHAPE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value code="C48348" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ROUND" xsi:type="CE"><originalText>circular</originalText></value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSIZE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value unit="mm" value="18" xsi:type="PQ" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSYMBOL" codeSystem="2.16.840.1.113883.1.11.19255" />
<value value="false" xsi:type="BL" />
</characteristic>
</subjectOf>
<consumedIn>
<substanceAdministration>
<routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ORAL" />
</substanceAdministration>
</consumedIn>
</manufacturedProduct>
</subject>
<subject>
<manufacturedProduct>
<manufacturedMedicine>
<code code="63304-761" codeSystem="2.16.840.1.113883.6.69" />
<name>AMOXICILLIN</name>
<formCode code="C42893" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET, CHEWABLE" />
<activeIngredient>
<quantity>
<numerator unit="mg" value="400">
<translation code="C28253" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLIGRAM" value="400" />
</numerator>
<denominator unit="1" value="1">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="1" />
</denominator>
</quantity>
<activeIngredientSubstance>
<code code="804826J2HU" codeSystem="2.16.840.1.113883.4.9" displayName="AMOXICILLIN" />
<name>amoxicillin</name>
<activeMoiety>
<activeMoiety>
<code code="804826J2HU" codeSystem="2.16.840.1.113883.4.9" displayName="AMOXICILLIN" />
<name>amoxicillin</name>
</activeMoiety>
</activeMoiety>
</activeIngredientSubstance>
</activeIngredient>
<asEntityWithGeneric>
<genericMedicine>
<name>Amoxicillin</name>
</genericMedicine>
</asEntityWithGeneric>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="Z0H242BBR1" codeSystem="2.16.840.1.113883.4.9" />
<name>aspartame</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>crospovidone</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>FD&amp;C red no. 40 aluminum lakes</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="70097M6I30" codeSystem="2.16.840.1.113883.4.9" />
<name>magnesium stearate</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="3OWL53L36A" codeSystem="2.16.840.1.113883.4.9" />
<name>mannitol</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>strawberry guarana flavor</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<asContent>
<quantity>
<numerator unit="1" value="20">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="20" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-761-20" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="100">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="100" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-761-01" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="1" value="500">
<translation code="C48542" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TABLET" value="500" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-761-05" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
</manufacturedMedicine>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLCOATING" codeSystem="2.16.840.1.113883.1.11.19255" />
<value value="false" xsi:type="BL" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLCOLOR" codeSystem="2.16.840.1.113883.1.11.19255" />
<value code="C48328" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="pink" xsi:type="CE"><originalText>light pink</originalText></value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLIMPRINT" codeSystem="2.16.840.1.113883.1.11.19255" />
<value xsi:type="ST">RX761</value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSCORE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value nullFlavor="OTH" xsi:type="PQ" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSHAPE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value code="C48348" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ROUND" xsi:type="CE"><originalText>circular</originalText></value>
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSIZE" codeSystem="2.16.840.1.113883.1.11.19255" />
<value unit="mm" value="14" xsi:type="PQ" />
</characteristic>
</subjectOf>
<subjectOf>
<characteristic classCode="OBS">
<code code="SPLSYMBOL" codeSystem="2.16.840.1.113883.1.11.19255" />
<value value="false" xsi:type="BL" />
</characteristic>
</subjectOf>
<consumedIn>
<substanceAdministration>
<routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ORAL" />
</substanceAdministration>
</consumedIn>
</manufacturedProduct>
</subject>
<subject>
<manufacturedProduct>
<manufacturedMedicine>
<code code="63304-969" codeSystem="2.16.840.1.113883.6.69" />
<name>AMOXICILLIN</name>
<formCode code="C42994" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUSPENSION" />
<activeIngredient>
<quantity>
<numerator unit="mg" value="200">
<translation code="C28253" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLIGRAM" value="200" />
</numerator>
<denominator unit="mL" value="5">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="5" />
</denominator>
</quantity>
<activeIngredientSubstance>
<code code="804826J2HU" codeSystem="2.16.840.1.113883.4.9" displayName="AMOXICILLIN" />
<name>amoxicillin</name>
<activeMoiety>
<activeMoiety>
<code code="804826J2HU" codeSystem="2.16.840.1.113883.4.9" displayName="AMOXICILLIN" />
<name>amoxicillin</name>
</activeMoiety>
</activeMoiety>
</activeIngredientSubstance>
</activeIngredient>
<asEntityWithGeneric>
<genericMedicine>
<name>Amoxicillin</name>
</genericMedicine>
</asEntityWithGeneric>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>colloidal silicon dioxide</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>FD&amp;C yellow no. 6</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>falvor strawberry guarana</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>favor tutti frutti</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="OJ245FE5EU" codeSystem="2.16.840.1.113883.4.9" />
<name>sodium benzoate</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="1Q73Q2JULR" codeSystem="2.16.840.1.113883.4.9" />
<name>sodium citrate</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="C151H8M554" codeSystem="2.16.840.1.113883.4.9" />
<name>sucrose</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>xanthan gum</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<asContent>
<quantity>
<numerator unit="mL" value="50">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="50" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-969-03" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="mL" value="75">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="75" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-969-01" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="mL" value="100">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="100" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-969-04" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
</manufacturedMedicine>
<consumedIn>
<substanceAdministration>
<routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ORAL" />
</substanceAdministration>
</consumedIn>
</manufacturedProduct>
</subject>
<subject>
<manufacturedProduct>
<manufacturedMedicine>
<code code="63304-970" codeSystem="2.16.840.1.113883.6.69" />
<name>AMOXICILLIN</name>
<formCode code="C42994" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SUSPENSION" />
<activeIngredient>
<quantity>
<numerator unit="mg" value="400">
<translation code="C28253" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLIGRAM" value="400" />
</numerator>
<denominator unit="mL" value="5">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="5" />
</denominator>
</quantity>
<activeIngredientSubstance>
<code code="804826J2HU" codeSystem="2.16.840.1.113883.4.9" displayName="AMOXICILLIN" />
<name>amoxicillin</name>
<activeMoiety>
<activeMoiety>
<code code="804826J2HU" codeSystem="2.16.840.1.113883.4.9" displayName="AMOXICILLIN" />
<name>amoxicillin</name>
</activeMoiety>
</activeMoiety>
</activeIngredientSubstance>
</activeIngredient>
<asEntityWithGeneric>
<genericMedicine>
<name>Amoxicillin</name>
</genericMedicine>
</asEntityWithGeneric>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>colloidal silicon dioxide</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>FD&amp;C yellow no. 6</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>falvor strawberry guarana</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>favor tutti frutti</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="OJ245FE5EU" codeSystem="2.16.840.1.113883.4.9" />
<name>sodium benzoate</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="1Q73Q2JULR" codeSystem="2.16.840.1.113883.4.9" />
<name>sodium citrate</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<code code="C151H8M554" codeSystem="2.16.840.1.113883.4.9" />
<name>sucrose</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>xanthan gum</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<asContent>
<quantity>
<numerator unit="mL" value="50">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="50" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-970-03" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="mL" value="75">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="75" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-970-01" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="mL" value="100">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="100" />
</numerator>
<denominator value="1">
<translation value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="63304-970-04" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE" />
</containerPackagedMedicine>
</asContent>
</manufacturedMedicine>
<consumedIn>
<substanceAdministration>
<routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ORAL" />
</substanceAdministration>
</consumedIn>
</manufacturedProduct>
</subject>
</section>
</component>
<component>
<section ID="INV-fbeaa703-297f-49c9-ae75-661b87106330">
<id root="8CD0500D-B8CB-10D5-07E3-5A1D3453E841" />
<code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION" />
<title ID="INV-f822240b-bab2-43ef-b79f-8b445174bf5b" />
<text ID="INV-df934489-addc-4a84-95d5-6dbed091e1d1"><paragraph ID="INV-183a7d68-4e86-43a4-b015-06d6a0fc424f"><content styleCode="bold">Rx only</content></paragraph><paragraph ID="INV-deacead9-b801-4063-b62b-24be39cd8e0f">To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin capsules, amoxicillin tablets, amoxicillin tablets (chewable) and amoxicillin for oral suspension and other antibacterial drugs, amoxicillin capsules, amoxicillin tablets, amoxicillin tablets (chewable) and amoxicillin for oral suspension should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.</paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
<component>
<section ID="INV-c20fadaa-fcc3-43a1-b123-a3eeb4118cda">
<id root="E20B9DD0-EC53-463A-DACC-6F0857058170" />
<code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION" />
<title ID="INV-de8124ce-008d-4d8a-9a32-a33bf3efc6dc">DESCRIPTION</title>
<text ID="INV-51f3ee0c-a6f1-45ac-b0ec-9039a643bab9"><paragraph ID="INV-18069c54-69a4-4903-9576-d2526bf489e8">Amoxicillin formulations contain amoxicillin, a semisynthetic antibiotic, an analog of ampicillin, with a broad spectrum of bactericidal activity against many gram-positive and gram-negative microorganisms. Chemically it is (2<content styleCode="italics">S</content>,5<content styleCode="italics">R</content>,6<content styleCode="italics">R</content>)-6-[(<content styleCode="italics">R</content>)-(-)-2- amino-2-(<content styleCode="italics">p</content>-hydroxyphenyl)acetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0] heptane-2-carboxylic acid trihydrate. It may be represented structurally as:</paragraph><renderMultiMedia referencedObject="MM-3d896df7-db61-4796-93fc-dfe5ebe2936d" /><paragraph ID="INV-f944662c-e643-49de-a777-9b94d840c1f3">The amoxicillin molecular formula is C<sub>16</sub>H<sub>19</sub>N<sub>3</sub>O<sub>5</sub>S&#8226;3H<sub>2</sub>O, and the molecular weight is 419.45.</paragraph><paragraph ID="INV-01e6c824-f58a-4d1b-99e9-7d4d80ec20e6">Amoxicillin capsules, tablets, and oral suspension are intended for oral administration.</paragraph><paragraph ID="INV-4e99ddb0-c845-4a8d-a214-905dfde881e4"><content styleCode="bold">Capsules: </content>Each amoxicillin capsule contains amoxicillin trihydrate equivalent to amoxicillin anhydrous 250 mg or 500 mg. Inactive ingredients: black iron oxide, colloidal silicon dioxide, croscarmellose sodium, D&amp;C Yellow No. 10, FD&amp;C Yellow No. 6, gelatin, magnesium stearate, microcrystalline cellulose, shellac, sodium lauryl sulfate and titanium dioxide. In addition 250 mg capsule contains FD&amp;C Red No. 40 and 500 mg capsule contains D&amp;C Red No. 28 and FD&amp;C Blue No. 1.</paragraph><paragraph ID="INV-fe932165-5e35-4e4c-8363-f901cd2425f3"><content styleCode="bold">Tablets: </content>Each amoxicillin tablet contains amoxicillin trihydrate equivalent to amoxicillin anhydrous 500 mg or 875 mg. Inactive ingredients: colloidal silicon dioxide, crospovidone, D&amp;C Red No. 30 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium starch glycolate, and titanium dioxide.</paragraph><paragraph ID="INV-3e5a36e2-fafa-40db-8e48-5a9d67f867cb"><content styleCode="bold">Chewable Tablets 125 mg and 250 mg:</content> Each amoxicillin chewable tablet contains amoxicillin trihydrate equivalent to amoxicillin anhydrous 125 mg, 200 mg, 250 mg or 400 mg. Inactive ingredients: aspartame&#8226;, FD&amp;C Red No. 40 aluminum lake, magnesium stearate, mannitol and strawberry guarana flavor.  Additionally the 125 mg and 250 mg tablets contain corn starch, compressible sugar and talc, while the 200 mg and 400 mg tablets contain crospovidone.</paragraph><paragraph ID="INV-30e20b2f-e91d-4590-9200-580f131723ee">&#8226;See <content styleCode="bold">PRECAUTIONS</content>.</paragraph><paragraph ID="INV-5d91d599-876d-4cbe-bb21-ca1bbaf0cd3c"><content styleCode="bold">Powder for Oral Suspension: </content>Each 5 mL of reconstituted suspension contains, 200 mg or 400 mg amoxicillin as the trihydrate.Each 5 mL of both the 200 mg and 400 mg reconstituted suspension contains 0.24 mEq (5.59 mg) of sodium.</paragraph><paragraph ID="INV-329b615f-3376-43a3-984d-67bd5b6f9036">Amoxicillin trihydrate for oral suspension 200 mg/5 mL and 400 mg/5 mL is (reconstituted) a fruity flavor containing inactive ingredients: colloidal silicon dioxide, FD&amp;C yellow no.6, flavor strawberry guarana, flavor tutti frutti, sodium benzoate, sodium citrate, sucrose, xanthan gum<content styleCode="bold">. </content></paragraph></text>
<effectiveTime value="20080519" />
<component>
<observationMedia ID="MM-3d896df7-db61-4796-93fc-dfe5ebe2936d">
<text />
<value mediaType="image/JPEG"><reference value="image_1.JPG" /></value>
</observationMedia>
</component>
</section>
</component>
<component>
<section ID="INV-e5847900-2bbf-4fbf-ab83-27bc03ca1a65">
<id root="D5DD9F82-0E1A-3D2D-B295-DB09DE654886" />
<code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION" />
<title ID="INV-63e8dd02-1185-4311-8f7e-9c9b90753df3">CLINICAL PHARMACOLOGY</title>
<text ID="INV-01951a91-ff7e-4fa0-8b56-14d81c3a424c"><paragraph ID="INV-d2571754-5dc8-4df8-9f4c-a3cb218df77c">Amoxicillin is stable in the presence of gastric acid and is rapidly absorbed after oral administration. The effect of food on the absorption of amoxicillin from amoxicillin tablets and amoxicillin suspension has been partially investigated. The 400 mg and 875 mg formulations have been studied only when administered at the start of a light meal. However, food effect studies have not been performed with the 200 mg and 500 mg formulations. Amoxicillin diffuses readily into most body tissues and fluids, with the exception of brain and spinal fluid, except when meninges are inflamed. The half-life of amoxicillin is 61.3 minutes. Most of the amoxicillin is excreted unchanged in the urine; its excretion can be delayed by concurrent administration of probenecid. In blood serum, amoxicillin is approximately 20% protein-bound.</paragraph><paragraph ID="INV-91ce6938-74c3-484b-ab1d-3f1e7477a304">Orally administered doses of 250 mg and 500 mg amoxicillin capsules result in average peak blood levels 1 to 2 hours after administration in the range of 3.5 mcg/mL to 5 mcg/mL and 5.5 mcg/mL to 7.5 mcg/mL, respectively.</paragraph><paragraph ID="INV-8377a35a-0f2a-4e91-9eb7-6995d074bd0f">Mean amoxicillin pharmacokinetic parameters from an open, two-part, single-dose crossover bioequivalence study in 27 adults comparing 875 mg of amoxicillin with 875 mg of amoxicillin/ clavulanate potassium showed that the 875 g tablet of amoxicillin produces an AUC<sub>0</sub><sub>-&#8734;</sub> of 35.4 &#177;8.1 mcg&#8226;hr/mL and a C<sub>max</sub> of 13.8 &#177;4.1 mcg/mL. Dosing was at the start of a light meal following an overnight fast.</paragraph><paragraph ID="INV-5044c06f-d9d0-49e2-abb9-048f7f9cfca4">Orally administered doses of amoxicillin suspension, 125 mg/5 mL and 250 mg/5 mL, result in average peak blood levels 1 to 2 hours after administration in the range of 1.5 mcg/mL to 3 mcg/mL and 3.5 mcg/mL to 5 mcg/mL, respectively.</paragraph><paragraph ID="INV-5760bec7-ba8d-47e7-b329-567596559964">Oral administration of single doses of 400 mg amoxicillin chewable tablets and 400 mg/5 mL suspension to 24 adult volunteers yielded comparable pharmacokinetic data:</paragraph><table ID="INV-91f60ed6-c2e6-4a1d-8f4d-10ec6a0a121b" border="1" frame="border"><col width="204px" />
<col width="212px" />
<col width="204px" />
<tbody>
<tr><td align="center" styleCode="Botrule Lrule"> Dose<sup>&#8224;</sup> </td><td align="center" styleCode="Botrule"> AUC<sub>0-</sub><sub>&#8734;</sub> (mcg&#8226;hr/mL) </td><td align="center" styleCode="Botrule Rrule"> C<sub>max </sub>(mcg/mL)<sup>&#8225;</sup> </td></tr>
<tr><td styleCode="Botrule Lrule"> Amoxicillin </td><td align="center" styleCode="Botrule"> Amoxicillin
 (&#177; S.D.) </td><td align="center" styleCode="Botrule Rrule"> Amoxicillin
 (&#177;S.D.) </td></tr>
<tr><td styleCode="Botrule Lrule"> 400 mg (5 mL of suspension) </td><td align="center" styleCode="Botrule"> 17.1 (3.1) </td><td align="center" styleCode="Botrule Rrule"> 5.92 (1.62) </td></tr>
<tr><td styleCode="Botrule Lrule"> 400 mg (1 chewable tablet) </td><td align="center" styleCode="Botrule"> 17.9 (2.4) </td><td align="center" styleCode="Botrule Rrule"> 5.18 (1.64) </td></tr>
</tbody>
</table><paragraph ID="INV-2bda8a35-b900-467e-b3e5-c5b0adcc7587"><sup>&#8224;</sup> Administered at the start of a light meal.</paragraph><paragraph ID="INV-ad09bffb-36fd-4250-8e14-4a2252e1e2de"><sup>&#8225;</sup> Mean values of 24 normal volunteers. Peak concentrations   occurred approximately 1 hour after the dose.</paragraph><paragraph ID="INV-707ab178-1116-4937-bd52-984def385bc3">Detectable serum levels are observed up to 8 hours after an orally administered dose of amoxicillin.  Following a 1 gram dose and utilizing a special skin window technique to determine levels of the antibiotic, it was noted that therapeutic levels were found in the interstitial fluid.  Approximately 60% of an orally administered dose of amoxicillin is excreted in the urine within 6 to 8 hours.</paragraph><paragraph ID="INV-06677e30-0b0f-46a8-af2a-04a2534907a5"><content styleCode="bold">Microbiology: </content>Amoxicillin is similar to ampicillin in its bactericidal action against susceptible organisms during the stage of active multiplication. It acts through the inhibition of biosynthesis of cell wall mucopeptide. Amoxicillin has been shown to be active against most strains of the following microorganisms, both <content styleCode="italics">in vitro </content>and in clinical infections as described in the <content styleCode="bold">INDICATIONS AND USAGE </content>section.</paragraph><paragraph ID="INV-8efb7c43-dee9-42cc-a40c-c74c6f7c212a"><content styleCode="bold"><content styleCode="italics">Aerobic Gram-Positive Microorganisms:</content></content></paragraph><paragraph ID="INV-a9342c3e-df1d-4c5a-b4a0-2872bcdfdbd7"><content styleCode="italics">Enterococcus faecalis</content></paragraph><paragraph ID="INV-89038b37-48bb-4ab7-a90c-a747ed0ce266"><content styleCode="italics">Staphylococcus</content> spp.<sup>&#8224;</sup> (&#946;-lactamase-negative strains only)</paragraph><paragraph ID="INV-94cbf090-9dfb-48b0-a11a-7015fd0b3eda"><content styleCode="italics">Streptococcus pneumoniae</content></paragraph><paragraph ID="INV-c4bec9f2-c7da-4620-9980-846af4acddec"><content styleCode="italics">Streptococcus</content> spp. (&#945;- and &#946;-hemolytic strains only)</paragraph><paragraph ID="INV-2c189207-d23d-487e-b64c-988c866f7583"><sup>&#8224; </sup>Staphylococci which are susceptible to amoxicillin but resistant to methicillin/oxacillin should be considered as resistant to amoxicillin.</paragraph><paragraph ID="INV-95102f7e-8aa6-425a-80cd-42fbfbd588f7"><content styleCode="bold"><content styleCode="italics">Aerobic Gram-Negative Microorganisms:</content></content></paragraph><paragraph ID="INV-20bfb571-92ee-49bb-9e46-d8113b0731ef"><content styleCode="italics">Escherichia coli</content> (&#946;-lactamase-negative strains only)</paragraph><paragraph ID="INV-c9260806-922e-48ec-ac65-059093232bd7"><content styleCode="italics">Haemophilus influenzae</content> (&#946;-lactamase-negative strains only)</paragraph><paragraph ID="INV-2741c414-0886-4241-bde6-ad9960bf524d"><content styleCode="italics">Neisseria gonorrhoeae</content> (&#946;-lactamase-negative strains only)</paragraph><paragraph ID="INV-fa926505-0b42-42bb-8f3b-e5621b9e8b73"><content styleCode="italics">Proteus mirabilis</content> (&#946;-lactamase-negative strains only)</paragraph><paragraph ID="INV-476ef935-e282-4144-9d7d-05839fb7093b"><content styleCode="bold"><content styleCode="italics">Helicobacter:</content></content></paragraph><paragraph ID="INV-1f89cfb2-a2ce-4155-80bb-3426f447d82e"><content styleCode="italics">Helicobacter pylori</content></paragraph><paragraph ID="INV-d896dd0f-615f-4245-b055-0a4aaaa0fc21"><content styleCode="bold">Susceptibility Tests: <content styleCode="italics">Dilution Techniques:</content></content> Quantitative methods are used to determine antimicrobial minimum inhibitory concentrations (MICs). These MICs provide estimates of the susceptibility of bacteria to antimicrobial compounds. The MICs should be determined using a standardized procedure. Standardized procedures are based on a dilution method1 (broth or agar) or equivalent with standardized inoculum concentrations and standardized concentrations of <content styleCode="bold">ampicillin</content> powder. Ampicillin is sometimes used to predict susceptibility of S. <content styleCode="italics">pneumoniae</content> to amoxicillin; however, some intermediate strains have been shown to be susceptible to amoxicillin. Therefore, S. <content styleCode="italics">pneumoniae</content> susceptibility should be tested using amoxicillin powder. The MIC values should be interpreted according to the following criteria: </paragraph><paragraph ID="INV-3493c5dc-252d-4d26-ba7f-30f2265dd33c"><content styleCode="bold">For </content><content styleCode="bold">Gram-Positive Aerobes:</content></paragraph><paragraph ID="INV-96c7a153-c451-46fd-9ab9-db2ecf33e3dd"><content styleCode="italics">Enterococcus</content></paragraph><table ID="INV-465b0b10-021c-4218-8b41-434446f5553e" frame="void"><col width="184px" />
<col width="272px" />
<tbody>
<tr><td align="center" styleCode="Botrule"> <content styleCode="underline">MIC (mcg/mL)</content> </td><td styleCode="Botrule"> <content styleCode="underline">Interpretation</content><content styleCode="italics"> </content></td></tr>
<tr><td styleCode="Botrule">                   &#8804; 8 </td><td styleCode="Botrule"> Susceptible (S) </td></tr>
<tr><td styleCode="Botrule">                   &#8805; 16 </td><td styleCode="Botrule"> Resistant (R) </td></tr>
</tbody>
</table><paragraph ID="INV-053e657f-8866-40b6-bf70-4ec6c08448e8"><content styleCode="italics">Staphylococcus</content><sup>a</sup></paragraph><table ID="INV-a8e827d6-13a9-4dce-afda-3d95ce95e3c2" frame="void"><col width="184px" />
<col width="272px" />
<tbody>
<tr><td align="center" styleCode="Botrule"> <content styleCode="underline">MIC (mcg/mL)</content><content styleCode="italics"> </content></td><td styleCode="Botrule"> <content styleCode="underline">Interpretation</content><content styleCode="italics"> </content></td></tr>
<tr><td align="center" styleCode="Botrule"> &#8804; 0.25 </td><td styleCode="Botrule"> Susceptible (S) </td></tr>
<tr><td align="center" styleCode="Botrule"> &#8805; 0.5 </td><td styleCode="Botrule"> Resistant (R) </td></tr>
</tbody>
</table><paragraph ID="INV-2c8cd266-cb83-43ea-a0a0-b872fba9f86b"><content styleCode="italics">Streptococcus </content>(except <content styleCode="italics">S. pneumoniae</content>)</paragraph><table ID="INV-86b527e0-e708-4d18-ba70-ec82c4826551" frame="void"><col width="184px" />
<col width="272px" />
<tbody>
<tr><td align="center" styleCode="Botrule"> <content styleCode="underline">MIC (mcg/mL)</content><content styleCode="italics"> </content></td><td styleCode="Botrule"> <content styleCode="underline">Interpretation</content><content styleCode="italics"> </content></td></tr>
<tr><td align="center" styleCode="Botrule"> &#8804; 0.25 </td><td styleCode="Botrule"> Susceptible (S) </td></tr>
<tr><td align="center" styleCode="Botrule"> 0.5 to 4 </td><td styleCode="Botrule"> Intermediate (I) </td></tr>
<tr><td align="center" styleCode="Botrule"> &#8805; 8 </td><td styleCode="Botrule"> Resistant (R) </td></tr>
</tbody>
</table><paragraph ID="INV-c2fa5492-d8e3-44af-bb6a-2ff044554a38"><content styleCode="italics">S. pneumoniae</content><sup>b </sup>(From non-meningitis source.)</paragraph><paragraph ID="INV-35cefde6-eb9d-41a9-b210-114f2c76a70d">(<content styleCode="bold">Amoxicillin </content>powder should be used to determine susceptibility.)</paragraph><table ID="INV-32adaf91-1e83-4d90-92c4-7305c944a065" frame="void"><col width="184px" />
<col width="272px" />
<tbody>
<tr><td align="center" styleCode="Botrule"> <content styleCode="underline">MIC (mcg/mL)</content><content styleCode="italics"> </content></td><td styleCode="Botrule"> <content styleCode="underline">Interpretation</content><content styleCode="italics"> </content></td></tr>
<tr><td align="center" styleCode="Botrule">&#8804; 2 </td><td styleCode="Botrule"> Susceptible (S) </td></tr>
<tr><td align="center" styleCode="Botrule"> 4 </td><td styleCode="Botrule"> Intermediate (I) </td></tr>
<tr><td align="center" styleCode="Botrule"> &#8805; 8 </td><td styleCode="Botrule"> Resistant (R) </td></tr>
</tbody>
</table><paragraph ID="INV-a0baf03a-d77d-4ecb-b7ee-266b0dfcb635"><content styleCode="bold">NOTE</content>: These interpretive criteria are based on the recommended doses for respiratory tract infections.</paragraph><paragraph ID="INV-d0efc7f9-501f-4596-aa6c-b4fbbca79f37">For Gram-Negative Aerobes:</paragraph><paragraph ID="INV-d0d309ea-5417-41e2-abd2-d3017dfe95b4">Enterobacteriaceae</paragraph><table ID="INV-3ed946d5-8cbb-4e5e-bdbc-b3105dff25b3" frame="void"><col width="180px" />
<col width="276px" />
<tbody>
<tr><td align="center" styleCode="Botrule"> <content styleCode="underline">MIC (mcg/mL)</content><content styleCode="italics"> </content></td><td styleCode="Botrule"> <content styleCode="underline">Interpretation</content><content styleCode="italics"> </content></td></tr>
<tr><td align="center" styleCode="Botrule"> &#8804; 8 </td><td styleCode="Botrule"> Susceptible (S) </td></tr>
<tr><td align="center" styleCode="Botrule"> 16 </td><td styleCode="Botrule"> Intermediate (I) </td></tr>
<tr><td align="center" styleCode="Botrule"> &#8805; 32 </td><td styleCode="Botrule"> Resistant (R) </td></tr>
</tbody>
</table><paragraph ID="INV-dbc52647-e84a-4b98-b710-1a4c337facbe"><content styleCode="italics">H. influenzae</content><sup>c</sup></paragraph><table ID="INV-ed9e999d-43ce-40d9-a71d-d8b7e53b81f6" frame="void"><col width="180px" />
<col width="276px" />
<tbody>
<tr><td align="center" styleCode="Botrule"> <content styleCode="underline">MIC (mcg/mL)</content><content styleCode="italics"> </content></td><td styleCode="Botrule"> <content styleCode="underline">Interpretation</content><content styleCode="italics"> </content></td></tr>
<tr><td align="center" styleCode="Botrule"> &#8804; 1 </td><td styleCode="Botrule"> Susceptible (S) </td></tr>
<tr><td align="center" styleCode="Botrule">    2</td><td styleCode="Botrule"> Intermediate (I) </td></tr>
<tr><td align="center" styleCode="Botrule"> &#8805; 4 </td><td styleCode="Botrule"> Resistant (R) </td></tr>
</tbody>
</table><paragraph ID="INV-78baa3e9-d617-4708-957f-ecab3d90d034"><sup>a</sup> Staphylococci which are susceptible to amoxicillin but resistant to methicillin/oxacillin should be considered as resistant to amoxicillin.</paragraph><paragraph ID="INV-f01ebc1d-1b16-405b-b0b2-b4cc5376401d"><sup>b</sup> These interpretive standards are applicable only to broth microdilution susceptibility tests using cation-adjusted Mueller-Hinton broth with 2-5% lysed horse blood.</paragraph><paragraph ID="INV-23f0ff00-4132-49d3-9701-afb176770103">   <sup>c</sup> These interpretive standards are applicable only to broth microdilution test with H. influenzae using Haemophilus Test Medium (HTM)<sup>1</sup>.</paragraph><paragraph ID="INV-b0e20573-7282-40d5-bf53-3b7426decf7b">A report of &#8220;Susceptible&#8221; indicates that the pathogen is likely to be inhibited if the antimicrobial compound in the blood reaches the concentrations usually achievable. A report of &#8220;Intermediate&#8221; indicates that the result should be considered equivocal, and, if the microorganism is not fully susceptible to alternative, clinically feasible drugs, the test should be repeated. This category implies possible clinical applicability in body sites where the drug is physiologically concentrated or in situations where high dosage of drug can be used. This category also provides a buffer zone, which prevents small uncontrolled technical factors from causing major discrepancies in interpretation. A report of &#8220;Resistant&#8221; indicates that the pathogen is not likely to be inhibited if the antimicrobial compound in the blood reaches the concentrations usually achievable; other therapy should be selected.</paragraph><paragraph ID="INV-819496d2-c93f-4481-926c-62647799a0be">Standardized susceptibility test procedures require the use of laboratory control microorganisms to control the technical aspects of the laboratory procedures. Standard <content styleCode="bold">ampicillin</content> powder should provide the following MIC values:</paragraph><table ID="INV-27206eb9-6c74-4dfd-a7be-00322aed37c8" frame="void"><col width="140px" />
<col width="136px" />
<col width="344px" />
<tbody>
<tr><td align="center" colspan="2" styleCode="Botrule"> <content styleCode="underline">Microorganism</content> </td><td styleCode="Botrule"> <content styleCode="underline">MIC</content><content styleCode="underline"> Range</content><content styleCode="underline"> (mcg/mL)</content> </td></tr>
<tr><td styleCode="Botrule"> <content styleCode="italics">E. coli</content>  </td><td styleCode="Botrule"> ATCC 25922 </td><td styleCode="Botrule"> 2 to 8 </td></tr>
<tr><td styleCode="Botrule"> <content styleCode="italics">E. faecalis</content>  </td><td styleCode="Botrule"> ATCC 29212 </td><td styleCode="Botrule"> 0.5 to 2 </td></tr>
<tr><td styleCode="Botrule"> <content styleCode="italics">H. influenzae</content>  </td><td styleCode="Botrule"> ATCC 49247<sup>d</sup> </td><td styleCode="Botrule"> 2 to 8 </td></tr>
<tr><td styleCode="Botrule"> <content styleCode="italics">S. aureus</content>  </td><td styleCode="Botrule"> ATCC 29213 </td><td styleCode="Botrule"> 0.25 to 1 </td></tr>
</tbody>
</table><paragraph ID="INV-57e9bf77-f630-4314-bce8-b90df157452c">Using <content styleCode="bold">amoxicillin </content>to determine susceptibility</paragraph><table ID="INV-87c5a06a-dda4-447a-a5be-2033426ceef3" frame="void"><col width="140px" />
<col width="136px" />
<col width="344px" />
<tbody>
<tr><td align="center" colspan="2" styleCode="Botrule"> <content styleCode="underline">Microorganism</content><content styleCode="italics"> </content></td><td styleCode="Botrule"> <content styleCode="underline">MIC</content><content styleCode="underline"> Range</content><content styleCode="underline"> (mcg/mL)</content><content styleCode="italics"> </content></td></tr>
<tr><td styleCode="Botrule"> <content styleCode="italics">S. pneumoniae</content>  </td><td styleCode="Botrule"> ATCC 49619<sup>e</sup> </td><td styleCode="Botrule"> 0.03 to 0.12 </td></tr>
</tbody>
</table><paragraph ID="INV-9851a51a-0026-4d57-9b72-c0bda1a3e379"><sup>d</sup> This quality control range is applicable to only <content styleCode="italics">H. influenzae </content>ATCC 49247 tested by a broth microdilution procedure using HTM.<sup>1</sup></paragraph><paragraph ID="INV-c4ef1f9d-8ad1-4a7b-a503-93cea654c432"><sup>e</sup> This quality control range is applicable to only <content styleCode="italics">S. pneumoniae </content>ATCC 49619 tested by the broth microdilution procedure using cation-adjusted Mueller-Hinton broth with 2 to 5% lysed horse blood.</paragraph><paragraph ID="INV-2a35a30b-14d2-4d4b-b4a7-ff96f0813676"><content styleCode="bold"><content styleCode="italics">Diffusion Techniques</content></content><content styleCode="bold">: </content>Quantitative methods that require measurement of zone diameters also provide reproducible estimates of the susceptibility of bacteria to antimicrobial compounds. One such standardized procedure<sup>2</sup> requires the use of standardized inoculum concentrations. This procedure uses paper disks impregnated with 10 mcg ampicillin to test the susceptibility of microorganisms, except <content styleCode="italics">S. pneumoniae</content>, to amoxicillin. Interpretation involves correlation of the diameter obtained in the disk test with the MIC for <content styleCode="bold">ampicillin</content>.</paragraph><paragraph ID="INV-32bbe817-1e95-4523-a44f-f8f50913d6b4">Reports from the laboratory providing results of the standard single-disk susceptibility test with a 10 mcg ampicillin disk should be interpreted according to the following criteria:</paragraph><paragraph ID="INV-ec8b00ac-ec44-4442-8600-6ae202a25eab"><content styleCode="bold">For Gram-Positive Aerobes:</content></paragraph><paragraph ID="INV-cf72aac8-d1c9-423f-ab2d-c6754c81946e"><content styleCode="italics">Enterococcus</content></paragraph><table ID="INV-8b7f510b-f4d1-4ac2-b9e9-3765b13ea035" frame="void"><col width="168px" />
<col width="272px" />
<tbody>
<tr><td align="center" styleCode="Botrule"> <content styleCode="underline">Zone Diameter (mm)</content> </td><td styleCode="Botrule"> <content styleCode="underline">Interpretation</content> </td></tr>
<tr><td align="center" styleCode="Botrule">&#8805; 17 </td><td styleCode="Botrule"> Susceptible (S) </td></tr>
<tr><td align="center" styleCode="Botrule"> &#8804; 16 </td><td styleCode="Botrule"> Resistant (R) </td></tr>
</tbody>
</table><paragraph ID="INV-41a93d44-dce2-47a5-a1dd-f2573facad46"><content styleCode="italics">Staphylococcus</content><sup>f</sup></paragraph><table ID="INV-40092726-0da9-435a-a6e5-f18b2ef25298" frame="void"><col width="172px" />
<col width="272px" />
<tbody>
<tr><td align="center" styleCode="Botrule"> <content styleCode="underline">Zone Diameter (mm)</content> </td><td styleCode="Botrule"> <content styleCode="underline">Interpretation</content> </td></tr>
<tr><td align="center" styleCode="Botrule">&#8805; 29 </td><td styleCode="Botrule"> Susceptible (S) </td></tr>
<tr><td align="center" styleCode="Botrule"> &#8804; 28 </td><td styleCode="Botrule"> Resistant (R) </td></tr>
</tbody>
</table><paragraph ID="INV-3429a496-b219-4d23-8cdf-d3f87e8e6dcc">&#946;-hemolytic streptococci</paragraph><table ID="INV-e72e2c22-545f-4774-a9af-2e3e4fcc433c" frame="void"><col width="172px" />
<col width="272px" />
<tbody>
<tr><td align="center" styleCode="Botrule"> <content styleCode="underline">Zone Diameter (mm)</content> </td><td styleCode="Botrule"> <content styleCode="underline">Interpretation</content> </td></tr>
<tr><td align="center" styleCode="Botrule"> &#8805; 26 </td><td styleCode="Botrule"> Susceptible (S) </td></tr>
<tr><td align="center" styleCode="Botrule"> 19 to 25 </td><td styleCode="Botrule"> Intermediate (I) </td></tr>
<tr><td align="center" styleCode="Botrule"> &#8804; 18 </td><td styleCode="Botrule"> Resistant (R) </td></tr>
</tbody>
</table><paragraph ID="INV-148010cf-73c0-41d2-967a-d7bff3fd8eea"><content styleCode="bold">NOTE: </content>For streptococci (other than &#946;-hemolytic streptococci and <content styleCode="italics">S. pneumoniae</content>), an ampicillin MIC should be determined.</paragraph><paragraph ID="INV-cc4b36c5-0036-4e69-82a0-81cc41fc8b9a"><content styleCode="italics">S. pneumoniae</content></paragraph><paragraph ID="INV-203f1cc7-91ed-42f6-b6f2-8aa84c9f6ddc"><content styleCode="italics">S. pneumoniae</content> should be tested using a 1 mcg oxacillin disk. Isolates with oxacillin zone sizes of &#8805; 20 mm are susceptible to amoxicillin. An amoxicillin MIC should be determined on isolates of <content styleCode="italics">S. pneumoniae</content> with oxacillin zone sizes of&#8804; 19 mm.</paragraph><paragraph ID="INV-7ac05afc-7012-4c07-a14f-c91e27cc7589"><content styleCode="bold">For Gram-Negative Aerobes:</content> </paragraph><paragraph ID="INV-56995b18-106f-4317-b68c-5a431911d3e1">Enterobacteriaceae</paragraph><table ID="INV-c6d45e02-829d-4fa3-be7e-bf31b3ca5a76" frame="void"><col width="180px" />
<col width="264px" />
<tbody>
<tr><td align="center" styleCode="Botrule"> <content styleCode="underline">Zone Diameter (mm)</content> </td><td styleCode="Botrule"> <content styleCode="underline">Interpretation</content> </td></tr>
<tr><td align="center" styleCode="Botrule"> &#8805; 17 </td><td styleCode="Botrule"> Susceptible (S) </td></tr>
<tr><td align="center" styleCode="Botrule"> 14 to 16 </td><td styleCode="Botrule"> Intermediate (I) </td></tr>
<tr><td align="center" styleCode="Botrule"> &#8804; 13 </td><td styleCode="Botrule"> Resistant (R) </td></tr>
</tbody>
</table><paragraph ID="INV-44d13b1f-c956-4262-a1c4-52a081d2e13d"><content styleCode="italics">H. influenzae</content><sup>g</sup></paragraph><table ID="INV-2972a4ce-ff03-42ea-bc7d-b54b70836b1f" frame="void"><col width="180px" />
<col width="264px" />
<tbody>
<tr><td styleCode="Botrule"> &#160; </td><td styleCode="Botrule"> &#160; </td></tr>
<tr><td align="center" styleCode="Botrule"> <content styleCode="underline">Zone Diameter (mm)</content> </td><td styleCode="Botrule"> <content styleCode="underline">Interpretation</content> </td></tr>
<tr><td align="center" styleCode="Botrule">&#8805; 22 </td><td styleCode="Botrule"> Susceptible (S) </td></tr>
<tr><td align="center" styleCode="Botrule"> 19 to 21 </td><td styleCode="Botrule"> Intermediate (I) </td></tr>
<tr><td align="center" styleCode="Botrule"> &#8804; 18 </td><td styleCode="Botrule"> Resistant (R) </td></tr>
</tbody>
</table><paragraph ID="INV-3355ccfd-d534-4bc8-a115-4615ce9725fa"><sup>f</sup>  Staphylococci which are susceptible to amoxicillin but resistant to methicillin/oxacillin should be considered as resistant to amoxicillin.</paragraph><paragraph ID="INV-e19896a8-0fff-47d5-8572-12dfce153d7c"><sup>g</sup>  These interpretive standards are applicable only to disk diffusion susceptibility tests with <content styleCode="italics">H. influenzae </content>using <content styleCode="italics">Haemophilus </content>Test Medium (HTM).<sup>2</sup></paragraph><paragraph ID="INV-332dc516-f60e-47f8-ba77-32bf59a102e5">Interpretation should be as stated above for results using dilution techniques.</paragraph><paragraph ID="INV-8e72fe6d-812e-4b41-a420-9b0a4810a1fd">     As with standard dilution techniques, disk diffusion susceptibility test procedures require the use of laboratory control microorganisms. The 10 mcg <content styleCode="bold">ampicillin </content>disk should provide the following zone diameters in these laboratory test quality control strains:</paragraph><table ID="INV-6662006b-3323-4bae-b5a1-cceead8a28a3" frame="void"><col width="136px" />
<col width="128px" />
<col width="352px" />
<tbody>
<tr><td align="center" colspan="2" styleCode="Botrule"> <content styleCode="underline">Microorganism</content> </td><td styleCode="Botrule"> <content styleCode="underline">Zone Diameter (mm)</content> </td></tr>
<tr><td styleCode="Botrule"> <content styleCode="italics">E. coli</content>  </td><td styleCode="Botrule"> ATCC 25922 </td><td styleCode="Botrule"> 16 to 22 </td></tr>
<tr><td styleCode="Botrule"> <content styleCode="italics">H. influenzae</content>  </td><td styleCode="Botrule"> ATCC 49247<sup>h</sup> </td><td styleCode="Botrule"> 13 to 21 </td></tr>
<tr><td styleCode="Botrule"> <content styleCode="italics">S. aureus</content>  </td><td styleCode="Botrule"> ATCC 25923 </td><td styleCode="Botrule"> 27 to 35 </td></tr>
</tbody>
</table><paragraph ID="INV-566e53a6-c2aa-4fb3-8614-c06c1cce7228">Using 1 mcg <content styleCode="bold">oxacillin </content>disk:</paragraph><table ID="INV-6395bf98-41ff-49fb-8de6-6f77eb919b74" frame="void"><col width="136px" />
<col width="128px" />
<col width="352px" />
<tbody>
<tr><td align="center" colspan="2" styleCode="Botrule"> <content styleCode="underline">Microorganism</content><content styleCode="italics"> </content></td><td align="center" styleCode="Botrule"> <content styleCode="underline">Zone Diameter (mm)</content> </td></tr>
<tr><td styleCode="Botrule"> <content styleCode="italics">S. pneumoniae</content>  </td><td styleCode="Botrule"> ATCC 49619<sup>i</sup> </td><td styleCode="Botrule"> 8 to 12 </td></tr>
</tbody>
</table><paragraph ID="INV-4f09137c-a04b-427c-9c5b-adb8d0327673"><sup>h</sup> This quality control range is applicable to only <content styleCode="italics">H. influenzae </content>ATCC 49247 tested by a disk diffusion procedure using HTM.<sup>2</sup></paragraph><paragraph ID="INV-6430f99e-ee36-439e-994d-f8f46e05b28d">i This quality control range is applicable to only <content styleCode="italics">S.  pneumoniae </content>ATCC 49619 tested by a disk diffusion procedure using Mueller-Hinton agar supplemented with 5% sheep blood and incubated in 5% CO<sub>2</sub>.</paragraph><paragraph ID="INV-794a7663-02bd-4ee7-88b4-5ad2ba636670"><content styleCode="bold">Susceptibility Testing for <content styleCode="italics">Helicobacter pylori: </content></content><content styleCode="italics">In vitro</content> susceptibility testing methods and diagnostic products currently available for determining minimum inhibitory concentrations (MICs) and zone sizes have not been standardized, validated, or approved for testing <content styleCode="italics">H. pylori</content> microorganisms.</paragraph><paragraph ID="INV-ef5e2b1b-9df2-490c-9296-aa1dd3054ffa">Culture and susceptibility testing should be obtained in patients who fail triple therapy. If clarithromycin resistance is found, a non-clarithromycin-containing regimen should be used.</paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
<component>
<section ID="INV-1926e98f-fdf4-41cf-baae-fc7b3aa78421">
<id root="301B34BB-A8C8-FE1C-28B2-ED1320CAB66C" />
<code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS AND USAGE SECTION" />
<title ID="INV-13f76e93-08f5-40e3-a5fc-e95994308825">INDICATIONS AND USAGE</title>
<text ID="INV-bd688152-0d4c-457f-af6f-c41065e3566d"><paragraph ID="INV-90e797e5-5ba5-46e5-bfd8-27c4cfb57c9d">Amoxicillin is indicated in the treatment of infections due to susceptible (ONLY &#946;-lactamase-negative) strains of the designated microorganisms in the conditions listed below:</paragraph><paragraph ID="INV-45dcd539-a390-45c4-8dd9-b07cd59408bc"><content styleCode="bold">Infections of the ear, nose, and throat -</content> due to <content styleCode="italics">Streptococcus</content> spp. (&#945;- and &#946;-hemolytic strains only), <content styleCode="italics">S. pneumoniae</content>, <content styleCode="italics">Staphylococcus</content> spp., or <content styleCode="italics">H. influenzae.</content></paragraph><paragraph ID="INV-70b4798f-5771-4304-be2a-fb6ea4c5c4c2"><content styleCode="bold">Infections of the genitourinary tract -</content> due to <content styleCode="italics">E. coli, P. mirabilis,</content> or <content styleCode="italics">E. faecalis.</content></paragraph><paragraph ID="INV-5979572d-218a-4371-8cba-f2c9bfbba2ce"><content styleCode="bold">Infections of the skin and skin structure</content> - due to <content styleCode="italics">Streptococcus</content> spp. (&#945;- and &#946;-hemolytic strains only), <content styleCode="italics">Staphylococcus</content> spp., or <content styleCode="italics">E. coli.</content></paragraph><paragraph ID="INV-610a5e76-19c2-43be-9445-a735e5189289"><content styleCode="bold">Infections of the lower respiratory tract</content> -due to <content styleCode="italics">Streptococcus</content> spp. (&#945;- and &#946;-hemolytic strains only), <content styleCode="italics">S</content>.<content styleCode="italics"> pneumoniae, Staphylococcus</content> spp., or <content styleCode="italics">H. influenzae</content>.</paragraph><paragraph ID="INV-6f6fb8de-98fc-4ede-ae3e-a8d2e8f8b485"><content styleCode="bold">Gonorrhea, acute uncomplicated (ano-genital and urethral infections)</content> - due to <content styleCode="italics">N. gonorrhoeae</content> (males and females).</paragraph><paragraph ID="INV-0511aee4-8d2a-4ec0-b976-4ac3dbe89c99"><content styleCode="italics">H. pylori</content> eradication to reduce the risk of duodenal ulcer recurrence</paragraph><paragraph ID="INV-ca30ee9b-a4d0-423e-91a3-a2caeb6ba3ce"><content styleCode="bold">Triple Therapy:</content> Amoxicillin/clarithromycin/lansoprazole</paragraph><paragraph ID="INV-a9d756b1-9b25-45ca-9db6-cad463b27a6d">Amoxicillin, in combination with clarithromycin plus lansoprazole as triple therapy, is indicated for the treatment of patients with <content styleCode="italics">H. pylori</content> infection and duodenal ulcer disease (active or 1-year history of a duodenal ulcer) to eradicate <content styleCode="italics">H. pylori.</content> Eradication of <content styleCode="italics">H. pylori</content> has been shown to reduce the risk of duodenal ulcer recurrence. (See <content styleCode="bold">CLINICAL STUDIES </content>and <content styleCode="bold">DOSAGE AND ADMINISTRATION</content>.)</paragraph><paragraph ID="INV-6f06ad03-978b-4e27-bf43-ac4d63a95d3e"><content styleCode="bold">Dual Therapy:</content> Amoxicillin/lansoprazole</paragraph><paragraph ID="INV-72a59273-8fbb-4e8f-9bce-20ea10c315d6">Amoxicillin, in combination with lansoprazole delayed-release capsules as dual therapy, is indicated for the treatment of patients with <content styleCode="italics">H. pylori</content> infection and duodenal ulcer disease (active or 1-year history of a duodenal ulcer) <content styleCode="bold">who are either allergic or intolerant to clarithromycin or in whom resistance to clarithromycin is known or suspected. </content>(See the clarithromycin package insert, <content styleCode="bold">MICROBIOLOGY</content>.) Eradication of <content styleCode="italics">H. pylori</content> has been shown to reduce the risk of duodenal ulcer recurrence. (See <content styleCode="bold">CLINICAL STUDIES </content>and <content styleCode="bold">DOSAGE AND ADMINISTRATION</content>.)</paragraph><paragraph ID="INV-6f1c2217-420f-4490-b704-8be5d44a61d0">To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin capsules, amoxicillin tablets, amoxicillin tablets (chewable) and amoxicillin for oral suspension and other antibacterial drugs, amoxicillin capsules, amoxicillin tablets, amoxicillin tablets (chewable) and amoxicillin for oral suspension should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.  When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy.  In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.</paragraph><paragraph ID="INV-30c51caf-2dbb-467c-94fc-3d2d645ec064">Indicated surgical procedures should be performed.</paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
<component>
<section ID="INV-8bcdf112-8251-4ca4-beae-a16425499386">
<id root="E76F5FC6-CA81-2342-A954-9A81E964C732" />
<code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION" />
<title ID="INV-8653db66-9e50-4802-aaac-9a8b6ea3b166">CONTRAINDICATIONS</title>
<text ID="INV-82dc4233-d28b-4ef8-9b15-2c5e9efb121b"><paragraph ID="INV-6d04ccd5-92e8-4577-87cc-673768007208">A history of allergic reaction to any of the penicillins is a contraindication.</paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
<component>
<section ID="INV-da252b4b-37d5-464b-aefd-decb83d8476b">
<id root="2B08ACBB-470C-A404-C96B-5B238CC43CDA" />
<code code="34071-1" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS SECTION" />
<title ID="INV-65b44e56-20d5-4d33-9602-62fcfa658303">WARNINGS</title>
<text ID="INV-b5d9acb5-0e5c-4e52-b367-6c7a1683963b"><paragraph ID="INV-bd8519f7-0aac-46b4-ae44-1d551fc5fe40">SERIOUS AND OCCASIONALLY FATAL HYPERSENSITIVITY (ANAPHYLACTIC) REACTIONS HAVE BEEN REPORTED IN PATIENTS ON PENICILLIN THERAPY. ALTHOUGH ANAPHYLAXIS IS MORE FREQUENT FOLLOWING PARENTERAL THERAPY, IT HAS OCCURRED IN PATIENTS ON ORAL PENICILLINS. THESE REACTIONS ARE MORE LIKELY TO OCCUR IN INDIVIDUALS WITH A HISTORY OF PENICILLIN HYPERSENSITIVITY AND/OR A HISTORY OF SENSITIVITY TO MULTIPLE ALLERGENS. THERE HAVE BEEN REPORTS OF INDIVIDUALS WITH A HISTORY OF PENICILLIN HYPERSENSITIVITY WHO HAVE EXPERIENCED SEVERE REACTIONS WHEN TREATED WITH CEPHALOSPORINS. BEFORE INITIATING THERAPY WITH AMOXICILLIN, CAREFUL INQUIRY SHOULD BE MADE CONCERNING PREVIOUS HYPERSENSITIVITY REACTIONS TO PENICILLINS, CEPHALOSPORINS, OR OTHER ALLERGENS. IF AN ALLERGIC REACTION OCCURS, AMOXICILLIN SHOULD BE DISCONTINUED AND APPROPRIATE THERAPY INSTITUTED. <content styleCode="bold">SERIOUS ANAPHYLACTIC REACTIONS REQUIRE IMMEDIATE EMERGENCY TREATMENT WITH EPINEPHRINE. OXYGEN, INTRAVENOUS STEROIDS, AND AIRWAY MANAGEMENT, INCLUDING INTUBATION, SHOULD ALSO BE ADMINISTERED AS INDICATED.</content></paragraph><paragraph ID="INV-1fffccd2-4f9d-447c-a8ec-4096d666455b"><content styleCode="italics">Clostridium difficile </content>associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including amoxicillin, and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of <content styleCode="italics">C. difficile.</content></paragraph><paragraph ID="INV-a28cbfc4-dae6-4cd7-911c-51ed6c54676d"><content styleCode="italics">C. difficile </content>produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing strains of <content styleCode="italics">C. difficile </content>cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhea following antibiotic use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents.</paragraph><paragraph ID="INV-d03b2bc6-d4f4-4177-a9aa-bbfc4fbd5fdf">If CDAD is suspected or confirmed, ongoing antibiotic use not directed against <content styleCode="italics">C. difficile </content>may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of <content styleCode="italics">C. difficile</content>, and surgical evaluation should be instituted as clinically indicated.</paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
<component>
<section ID="INV-48a82f00-8418-4c77-9981-438854c345ec">
<id root="617126DE-5135-B4CA-A2B0-240094643D57" />
<code code="42232-9" codeSystem="2.16.840.1.113883.6.1" displayName="PRECAUTIONS SECTION" />
<title ID="INV-b7732883-2bec-4499-8aef-441704fb313e">PRECAUTIONS</title>
<effectiveTime value="20080519" />
<component>
<section ID="INV-91df22c0-1721-440a-a76c-46251593a6ab">
<id root="FE68CD4B-036B-C2B9-FB21-53F4FECECEF9" />
<code code="34072-9" codeSystem="2.16.840.1.113883.6.1" displayName="GENERAL PRECAUTIONS SECTION" />
<title ID="INV-033cd7a0-cf2d-4354-9356-e44bbdad7389"><content styleCode="bold">General:</content></title>
<text ID="INV-22a777a1-4ef7-425a-b55f-f55748b43d64"><paragraph ID="INV-887de1c1-02c3-4217-a898-7088cdc31e37">The possibility of superinfections with mycotic or bacterial pathogens should be kept in mind during therapy. If superinfections occur, amoxicillin should be discontinued and appropriate therapy instituted.</paragraph><paragraph ID="INV-200c1eb2-ebed-449d-8072-2b7b953d4c4e">A high percentage of patients with mononucleosis who receive ampicillin develop an erythematous skin rash. Thus, ampicillin-class antibiotics should not be administered to patients with mononucleosis. </paragraph><paragraph ID="INV-8aa5a255-779a-4a32-a21a-96891920b104"> Prescribing amoxicillin capsules, amoxicillin tablets, amoxicillin tablets (chewable) and amoxicillin for oral suspension in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.</paragraph><paragraph ID="INV-2a791033-3de6-4418-baa3-1e2c02dfe769"><content styleCode="bold">Phenylketonurics: </content>Each 125 mg amoxicillin tablet (chewable) contains 1.4 mg phenylalanine; each 200 mg chewable tablet contains 4.5 mg phenylalanine; each 250 mg chewable tablet contains 2.8 mg phenylalanine; each 400 mg chewable tablet contains 9 mg phenylalanine.</paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
<component>
<section ID="INV-c9563b6a-73cd-43c7-8549-f1a803f9543a">
<id root="4F349ADE-AE2E-1165-BDD1-74575810CA28" />
<code code="34075-2" codeSystem="2.16.840.1.113883.6.1" displayName="LABORATORY TESTS SECTION" />
<title ID="INV-831d41ba-4893-4bb3-a3fe-a0384a7c8bb4"><content styleCode="bold">Laboratory Tests:</content></title>
<text ID="INV-c524f59f-f0d1-48ab-a318-6c6c56bdbb53"><paragraph ID="INV-3d07605e-c1e9-46bb-8bbb-6c42225ce4c0">As with any potent drug, periodic assessment of renal, hepatic, and hematopoietic function should be made during prolonged therapy.</paragraph><paragraph ID="INV-226f35f9-a577-48ef-9839-d435f98580aa">All patients with gonorrhea should have a serologic test for syphilis at the time of diagnosis. Patients treated with amoxicillin should have a follow-up serologic test for syphilis after 3 months.</paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
<component>
<section ID="INV-18d9d38c-a797-4a00-a3d8-1b01ebf61ee4">
<id root="75427ED7-02FF-A0F3-0022-34D9EDBE8E21" />
<code code="34073-7" codeSystem="2.16.840.1.113883.6.1" displayName="DRUG INTERACTIONS SECTION" />
<title ID="INV-7adf6f10-b45b-4928-8d17-d91cf78438c8"><content styleCode="bold">Drug Interactions:</content></title>
<text ID="INV-53c7af1d-9c59-4581-82a5-e1d76303b2d2"><paragraph ID="INV-e37f616f-4d14-4c70-8399-a903bca718e3">Probenecid decreases the renal tubular secretion of amoxicillin. Concurrent use of amoxicillin and probenecid may result in increased and prolonged blood levels of amoxicillin.</paragraph><paragraph ID="INV-6fac0d65-7faa-4ede-a282-8966fb1a6699">	Chloramphenicol, macrolides, sulfonamides, and tetracyclines may interfere with the bactericidal effects of penicillin. This has been demonstrated in vitro; however, the clinical significance of this interaction is not well documented.</paragraph><paragraph ID="INV-869ada52-3b1f-47fe-8179-f43f04d05c94">In common with other antibiotics, amoxicillin may affect the gut flora, leading to lower estrogen reabsorption and reduced efficacy of combined oral estrogen/progesterone contraceptives. </paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
<component>
<section ID="INV-23a5019a-bccb-439e-a9cb-47c3f8beb689">
<id root="DC58FC0A-2B9D-5EF8-E870-567DB41E8B01" />
<code code="34074-5" codeSystem="2.16.840.1.113883.6.1" displayName="DRUG AND/OR LABORATORY TEST INTERACTIONS SECTION" />
<title ID="INV-16475409-e4c5-47ae-872a-3b6bea859a4b"><content styleCode="bold">Drug/Laboratory Test Interactions:</content></title>
<text ID="INV-a1fa4f2f-948b-404f-af08-e464f87ef48b"><paragraph ID="INV-076b4346-3a78-48ed-823f-69c2fc0f6c2e">High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using CLINITEST<sup>&#174;</sup>, Benedict&#8217;s Solution, or Fehling&#8217;s Solution. Since this effect may also occur with amoxicillin, it is recommended that glucose tests based on enzymatic glucose oxidase reactions (such as CLINISTIX<sup>&#174;</sup>) be used.</paragraph><paragraph ID="INV-8b254f1f-c01a-4fd9-8255-ee0573f14c3c">Following administration of ampicillin to pregnant women, a transient decrease in plasma concentration of total conjugated estriol, estriol-glucuronide, conjugated estrone, and estradiol has been noted. This effect may also occur with amoxicillin.</paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
<component>
<section ID="INV-1254a1a9-5761-4431-9d25-96fd3ee856b8">
<id root="D0C392E1-260F-912A-7A8B-E89D841797C6" />
<code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="CARCINOGENESIS AND MUTAGENESIS AND IMPAIRMENT OF FERTILITY SECTION" />
<title ID="INV-f9d7e056-3844-42df-9364-3d0d290a8351"><content styleCode="bold">Carcinogenesis, Mutagenesis, Impairment of Fertility:</content></title>
<text ID="INV-43cc6920-3445-4619-9d86-ee9edd8412ed"><paragraph ID="INV-57fbf904-cbac-417e-856c-13066d12d176">Long-term studies in animals have not been performed to evaluate carcinogenic potential. Studies to detect mutagenic potential of amoxicillin alone have not been conducted; however, the following information is available from tests on a 4:1 mixture of amoxicillin and potassium clavulanate. Amoxicillin and potassium clavulanate was non-mutagenic in the Ames bacterial mutation assay, and the yeast gene conversion assay. Amoxicillin and potassium clavulanate was weakly positive in the mouse lymphoma assay, but the trend toward increased mutation frequencies in this assay occurred at doses that were also associated with decreased cell survival.</paragraph><paragraph ID="INV-82b60af9-588a-48ac-b7a5-74e49eec2193">Amoxicillin and potassium clavulanate was negative in the mouse micronucleus test, and in the dominant lethal assay in mice. Potassium clavulanate alone was tested in the Ames bacterial mutation assay and in the mouse micronucleus test, and was negative in each of these assays. In a multi-generation reproduction study in rats, no impairment of fertility or other adverse reproductive effects were seen at doses up to 500 mg/kg (approximately 3 times the human dose in mg/m<sup>2</sup>).</paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
<component>
<section ID="INV-edff1659-ff0f-4ee9-afa6-f57c48df1843">
<id root="73D43BED-05FE-0770-C7DA-B7B4828329BA" />
<code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION" />
<title ID="INV-43f7543a-57eb-4f3c-a0be-6d0e0c352096"><content styleCode="bold">Pregnancy:</content></title>
<text ID="INV-28c07b2e-bc6a-401d-b9ad-5336cb2fb3c6"><paragraph ID="INV-13b5c135-1191-4d64-8c6a-b66b9a9ed43a"><content styleCode="bold"><content styleCode="italics">Teratogenic Effects. </content></content>Pregnancy Category B<content styleCode="bold"><content styleCode="italics">.</content> </content>Reproduction studies have been performed in mice and rats at doses up to 10 times the human dose and have revealed no evidence of impaired fertility or harm to the fetus due to amoxicillin. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.</paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
<component>
<section ID="INV-4d02b36f-0091-44e9-927d-54e760ba5ef3">
<id root="A8FAC56B-00CC-45B7-1FB0-8D1A8F5A9539" />
<code code="34079-4" codeSystem="2.16.840.1.113883.6.1" displayName="LABOR AND DELIVERY SECTION" />
<title ID="INV-8925c6bc-31a2-4e0a-92e6-3027631d6379"><content styleCode="bold">Labor and Delivery:</content></title>
<text ID="INV-47d4b350-64c4-4a38-8628-a8caef5d5784"><paragraph ID="INV-c9fc432d-9282-4d26-a2ca-ae867ed04c14">Oral ampicillin-class antibiotics are poorly absorbed during labor. Studies in guinea pigs showed that intravenous administration of ampicillin slightly decreased the uterine tone and frequency of contractions but moderately increased the height and duration of contractions. However, it is not known whether use of amoxicillin in humans during labor or delivery has immediate or delayed adverse effects on the fetus, prolongs the duration of labor, or increases the likelihood that forceps delivery or other obstetrical intervention or resuscitation of the newborn will be necessary.</paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
<component>
<section ID="INV-9ec4bd7e-ef30-40c1-82fd-a1d63115cd1f">
<id root="BCE209DA-D9FD-C164-32CB-FD76041FD5EC" />
<code code="34080-2" codeSystem="2.16.840.1.113883.6.1" displayName="NURSING MOTHERS SECTION" />
<title ID="INV-dccfa4c3-38d1-4ecf-a23e-b51af0503a20"><content styleCode="bold">Nursing Mothers:</content></title>
<text ID="INV-c459aabe-bb72-4ccf-8624-e3201c8b3ea7"><paragraph ID="INV-6ea99347-9a1d-49b1-ab6e-0f04cdfecef5">Penicillins have been shown to be excreted in human milk. Amoxicillin use by nursing mothers may lead to sensitization of infants. Caution should be exercised when amoxicillin is administered to a nursing woman.</paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
<component>
<section ID="INV-136a94c8-015f-4b83-abfc-e4d1b2558f40">
<id root="D2C46355-E631-52AD-A10C-2630A9DD2AF5" />
<code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION" />
<title ID="INV-95ded637-e52e-47be-8006-044794eddf72"><content styleCode="bold">Pediatric Use:</content></title>
<text ID="INV-6a903b92-35b5-48c8-ac66-da536ce4b5d9"><paragraph ID="INV-dda9c866-b2b7-4cb5-b7ed-0983427d5fd9">Because of incompletely developed renal function in neonates and young infants, the elimination of amoxicillin may be delayed. Dosing of amoxicillin should be modified in pediatric patients 12 weeks or younger (&#8804; 3 months). (See <content styleCode="bold">DOSAGE AND ADMINISTRATION</content>&#8211;<content styleCode="bold">Neonates and infants</content>.)</paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
<component>
<section ID="INV-6b86beb6-4d76-4843-9f0d-5d5bd0172fdc">
<id root="6EF4D4EB-CA86-3CB4-B008-CF7B2F0CBD3C" />
<code code="34082-8" codeSystem="2.16.840.1.113883.6.1" displayName="GERIATRIC USE SECTION" />
<title ID="INV-4c519625-13c4-437e-876a-96e3ca3949cc"><content styleCode="bold">Geriatric Use:</content></title>
<text ID="INV-ac1198c5-efe1-45c1-92fc-dbb43f993078"><paragraph ID="INV-3ffa13ac-2bb6-4ba2-bd7d-aba47066ca16">An analysis of clinical studies of amoxicillin was conducted to determine whether subjects aged 65 and over respond differently from younger subjects. Of the 1,811 subjects treated with capsules of amoxicillin, 85% were &lt; 60 years old, 15% were &#8805; 61 years old and 7% were &#8805; 71 years old. This analysis and other reported clinical experience have not identified differences in responses between the elderly and younger patients, but a greater sensitivity of some older individuals cannot be ruled out. </paragraph><paragraph ID="INV-3f23d200-c274-41ce-87c0-94ff14cb5c89">This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.</paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
<component>
<section ID="INV-9c2e855d-62da-47c9-bfd5-448a7b634638">
<id root="40973763-D35E-3A63-2833-81E180989A37" />
<code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION" />
<title ID="INV-68699599-db8d-4309-b569-6970465fe10b"><content styleCode="bold">Information for Patients:</content></title>
<text ID="INV-3f236e1b-7857-4a38-a521-cce5bd10f6d3"><paragraph ID="INV-78dcb2c4-363a-4c92-b812-363c59d20370">Amoxicillin may be taken every 8 hours or every 12 hours, depending on the strength of the product prescribed.</paragraph><paragraph ID="INV-6d2c3903-5179-4081-b29b-60b8d70c67f8">Patients should be counseled that antibacterial drugs, including amoxicillin capsules, amoxicillin tablets, amoxicillin tablets (chewable) and amoxicillin for oral suspension should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When amoxicillin capsules, amoxicillin tablets, amoxicillin tablets (chewable) and amoxicillin for oral suspension is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may: (1) decrease the effectiveness of the immediate treatment, and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by amoxicillin capsules, amoxicillin tablets, amoxicillin tablets (chewable) and amoxicillin for oral suspension or other antibacterial drugs in the future.</paragraph><paragraph ID="INV-402afdc9-5b9f-4ac8-ab84-3dfc063fbfdc">Diarrhea is a common problem caused by antibiotics which usually ends when the antibiotic is discontinued. Sometimes after starting treatment with antibiotics, patients can develop watery and bloody stools (with or without stomach cramps and fever) even as late as 2 or more months after having taken the last dose of the antibiotic. If this occurs, patients should contact their physician as soon as possible.</paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
</section>
</component>
<component>
<section ID="INV-d05ecdb9-b5ea-49ef-bcd8-009d08c8d8d0">
<id root="AD11BD44-588B-58C1-F626-0F5E4B0C5E7D" />
<code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION" />
<title ID="INV-f6a2f525-c2c3-447a-9679-c0d31964c23a">ADVERSE REACTIONS</title>
<text ID="INV-ea30959d-80c7-4d7e-be0b-0c7ef6007e25"><paragraph ID="INV-7c559d46-c05a-434a-9bfc-32b5aa3a1031">As with other penicillins, it may be expected that untoward reactions will be essentially limited to sensitivity phenomena. They are more likely to occur in individuals who have previously demonstrated hypersensitivity to penicillins and in those with a history of allergy, asthma, hay fever, or urticaria. The following adverse reactions have been reported as associated with the use of penicillins:</paragraph><paragraph ID="INV-142755e1-c5f9-4db6-8855-dd4dcc526bcd"><content styleCode="bold">Infections and Infestations: </content>Mucocutaneous candidiasis.</paragraph><paragraph ID="INV-d17a0346-31d4-4422-933a-1c9013281fdc"><content styleCode="bold">Gastrointestinal</content>: Nausea, vomiting, diarrhea, black hairy tongue, and hemorrhagic/pseudomembranous colitis. </paragraph><paragraph ID="INV-4c728367-5637-44b1-85ab-abbb0c7d8d2f">Onset of pseudomembranous colitis symptoms may occur during or after antibiotic treatment. (See <content styleCode="bold">WARNINGS</content>.)</paragraph><paragraph ID="INV-0cd1243d-d9fb-4e81-a06b-efcc3c625b0a"><content styleCode="bold">Hypersensitivity Reactions:</content> Anaphylaxis (See <content styleCode="bold">WARNING</content>)</paragraph><paragraph ID="INV-cd79d9fa-b0ab-4d40-8f1b-858742a6ed4e">Serum sickness-like reactions, erythematous maculopapular rashes, erythema multiforme, Stevens-Johnson syndrome, exfoliative dermatitis, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, hypersensitivity vasculitis and urticaria have been reported.</paragraph><paragraph ID="INV-df375d26-353f-4503-b299-ad996255ef60"><content styleCode="bold">NOTE</content>: These hypersensitivity reactions may be controlled with antihistamines and, if necessary, systemic corticosteroids. Whenever such reactions occur, amoxicillin should be discontinued unless, in the opinion of the physician, the condition being treated is life-threatening and amenable only to amoxicillin therapy.</paragraph><paragraph ID="INV-22b82e81-c8cf-4441-92c7-06aeef5e798d"><content styleCode="bold">Liver:</content> A moderate rise in AST (SGOT) and/or ALT (SGPT) has been noted, but the significance of this finding is unknown. Hepatic dysfunction including cholestatic jaundice, hepatic cholestasis and acute cytolytic hepatitis have been reported.</paragraph><paragraph ID="INV-faba2d42-9519-494c-a191-f5a4f2f2bd2a"><content styleCode="bold">Renal:</content> Crystalluria has also been reported (see <content styleCode="bold">OVERDOSAGE</content>).</paragraph><paragraph ID="INV-8dec3f04-26cc-498e-9aa0-259499a7f90e"><content styleCode="bold">Hemic and Lymphatic Systems:</content> Anemia, including hemolytic anemia, thrombocytopenia, thrombocytopenic purpura, eosinophilia, leukopenia, and agranulocytosis have been reported during therapy with penicillins. These reactions are usually reversible on discontinuation of therapy and are believed to be hypersensitivity phenomena.</paragraph><paragraph ID="INV-5921df3a-8d07-421b-8eda-9351f43bfffa"><content styleCode="bold">Central Nervous System:</content> Reversible hyperactivity, agitation, anxiety, insomnia, confusion, convulsions, behavioral changes, and/or dizziness have been reported rarely.</paragraph><paragraph ID="INV-f7e30e51-d75d-4bac-9c52-a40efbb2a126"><content styleCode="bold">Miscellaneous:</content> Tooth discoloration (brown, yellow, or gray staining) has been rarely reported. Most reports occurred in pediatric patients. Discoloration was reduced or eliminated with brushing or dental cleaning in most cases.</paragraph><paragraph ID="INV-8191d349-d9e5-4f13-9235-2b81be7afba7"><content styleCode="bold">Combination Therapy with Clarithromycin and Lansoprazole: </content>In clinical trials using combination therapy with amoxicillin plus clarithromycin and lansoprazole, and amoxicillin plus lansoprazole, no adverse reactions peculiar to these drug combinations were observed. Adverse reactions that have occurred have been limited to those that had been previously reported with amoxicillin, clarithromycin, or lansoprazole.</paragraph><paragraph ID="INV-22830ae8-8e22-453f-a8fe-ed69fe84718c"><content styleCode="bold">Triple Therapy: <content styleCode="italics">Amoxicillin/Clarithromycin/Lansoprazole:</content> </content>The most frequently reported adverse events for patients who received triple therapy were diarrhea (7%), headache (6%), and taste perversion (5%). No treatment-emergent adverse events were observed at significantly higher rates with triple therapy than with any dual therapy regimen.</paragraph><paragraph ID="INV-7708391e-1fb1-4c5f-b66b-9c41c5dd3b78"><content styleCode="bold">Dual Therapy: <content styleCode="italics">Amoxicillin/Lansoprazole</content>: </content>The most frequently reported adverse events for patients who received amoxicillin three times daily plus lansoprazole three times daily dual therapy were diarrhea (8%) and headache (7%). No treatment-emergent adverse events were observed at significantly higher rates with amoxicillin three times daily plus lansoprazole three times daily dual therapy than with lansoprazole alone.</paragraph><paragraph ID="INV-d6662b0f-e897-454d-ac42-5cc58253297a">For more information on adverse reactions with clarithromycin or lansoprazole, refer to their package inserts, <content styleCode="bold">ADVERSE REACTIONS</content>.</paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
<component>
<section ID="INV-425fb58c-d0e5-4d04-9fe9-48e231bf1087">
<id root="E37BE530-987F-24CA-CB0B-5211FEF1371A" />
<code code="34088-5" codeSystem="2.16.840.1.113883.6.1" displayName="OVERDOSAGE SECTION" />
<title ID="INV-e412b4c4-1997-49e8-9c1c-52d0503ac9ee">OVERDOSAGE</title>
<text ID="INV-22dc9836-8c8f-43ba-8ad5-d0e1ec4f2e2c"><paragraph ID="INV-a6a466d8-9134-48a6-bb48-ffcc096c139d">In case of overdosage, discontinue medication, treat symptomatically, and institute supportive measures as required. If the overdosage is very recent and there is no contraindication, an attempt at emesis or other means of removal of drug from the stomach may be performed. A prospective study of 51 pediatric patients at a poison-control center suggested that overdosages of less than 250 mg/kg of amoxicillin are not associated with significant clinical symptoms and do not require gastric emptying.<sup>3</sup></paragraph><paragraph ID="INV-508e40fd-706a-4403-92fe-8a64bf6f21d6">Interstitial nephritis resulting in oliguric renal failure has been reported in a small number of patients after overdosage with amoxicillin.</paragraph><paragraph ID="INV-9aaa47c8-b98b-443e-a5ad-dd1e7ceaa2d2">Crystalluria, in some cases leading to renal failure, has also been reported after amoxicillin overdosage in adult and pediatric patients. In case of overdosage, adequate fluid intake and diuresis should be maintained to reduce the risk of amoxicillin crystalluria.</paragraph><paragraph ID="INV-21cb0512-a32f-43fc-969c-04181516ea74">Renal impairment appears to be reversible with cessation of drug administration. High blood levels may occur more readily in patients with impaired renal function because of decreased renal clearance of amoxicillin. Amoxicillin may be removed from circulation by hemodialysis.</paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
<component>
<section ID="INV-440a6592-41b4-47ea-bae1-365953249790">
<id root="8ED6911B-8597-900E-5C55-7283BCAEF4C2" />
<code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE AND ADMINISTRATION SECTION" />
<title ID="INV-1fbbefb7-3c07-4848-b06b-89e747333caa">DOSAGE AND ADMINISTRATION</title>
<text ID="INV-35d33330-269c-45a8-97af-1dda979c1c96"><paragraph ID="INV-0cd51a36-34f5-47ae-baf4-2e4b350869a2">Amoxicillin capsules, chewable tablets, and oral suspensions may be given without regard to meals. The 400 mg suspension, 400 mg chewable tablet and the 875 mg tablet have been studied only when administered at the start of a light meal. However, food effect studies have not been performed with the 200 mg and 500 mg formulations.</paragraph><paragraph ID="INV-3733253e-474e-4118-9e60-fea0911471b2">Amoxicillin tablets, chewable should be chewed before swallowing</paragraph><paragraph ID="INV-75a6a6b5-ab39-4546-9a0e-a1615af8b130"><content styleCode="bold">Neonates and Infants aged &#8804; 12 weeks (&#8804; 3 months): </content>Due to incompletely developed renal function affecting elimination of amoxicillin in this age group, the recommended upper dose of amoxicillin is 30 mg/kg/day divided q12h.</paragraph><paragraph ID="INV-e455785d-58c4-4436-8f7c-182540e74c61"><content styleCode="bold">Adults and Pediatric Patients &gt; 3 months</content></paragraph><table ID="INV-76976096-99c7-4e53-bf74-a5d8d5c52b68" frame="void"><col width="126px" />
<col width="112px" />
<col width="118px" />
<col width="265px" />
<tbody>
<tr><td styleCode="Botrule"> <content styleCode="bold">Infection</content> </td><td styleCode="Botrule"> <content styleCode="bold">Severity<sup>&#8225;</sup></content> </td><td styleCode="Botrule"> <content styleCode="bold">Usual Adult Dose</content> </td><td styleCode="Botrule"> <content styleCode="bold">Usual Dose for Children &gt;3 months<sup>&#167; &#960;</sup></content> </td></tr>
<tr><td styleCode="Botrule"> Ear/Nose/Throat </td><td styleCode="Botrule"> Mild/Moderate </td><td styleCode="Botrule"> 500 mg every12 hours or 250 mg every 8 hours  </td><td styleCode="Botrule"> 25 mg/kg/day in divided  doses every 12 hours<content styleCode="bold">  or </content>20 mg/kg/day in divided  doses every 8 hours </td></tr>
<tr><td styleCode="Botrule"> &#160; </td><td styleCode="Botrule"> Severe </td><td styleCode="Botrule"> 875 mg every 12 hours or 500 mg every 8 hours  </td><td styleCode="Botrule"> 45 mg/kg/day in divided  doses every 12 hours <content styleCode="bold">or </content>40 mg/kg/day in divided  doses every 8 hours </td></tr>
<tr><td styleCode="Botrule"> Lower Respiratory Tract </td><td styleCode="Botrule"> Mild/Moderate or Severe </td><td styleCode="Botrule"> 875 mg every 12 hours or 500 mg every 8 hours  </td><td styleCode="Botrule"> 45 mg/kg/day in divided  doses every 12 hours<content styleCode="bold">  or </content>40 mg/kg/day in divided  doses every 8 hours </td></tr>
<tr><td styleCode="Botrule"> Skin/Skin Structure </td><td styleCode="Botrule"> Mild/Moderate </td><td styleCode="Botrule"> 500 mg every12 hours or 250 mg every 8 hours </td><td styleCode="Botrule"> 25 mg/kg/day in divided  doses every 12 hours <content styleCode="bold">or </content>20 mg/kg/day in divided  doses every 8 hours </td></tr>
<tr><td styleCode="Botrule"> &#160; </td><td styleCode="Botrule"> Severe </td><td styleCode="Botrule"> 875 mg every12 hours or 500 mg every 8 hours </td><td styleCode="Botrule"> 45 mg/kg/day in divided  doses every 12 hours <content styleCode="bold">or </content>40 mg/kg/day in divided doses every 8 hours </td></tr>
<tr><td styleCode="Botrule"> Genitourinary Tract </td><td styleCode="Botrule"> Mild/Moderate </td><td styleCode="Botrule"> 500 mg every12 hours or 250 mg every 8 hours </td><td styleCode="Botrule"> 25 mg/kg/day in divided doses every 12 hours <content styleCode="bold">or </content>20 mg/kg/day in divided doses every 8 hours </td></tr>
<tr><td styleCode="Botrule"> &#160; </td><td styleCode="Botrule"> Severe </td><td styleCode="Botrule"> 875 mg every12 hours or 500 mg every 8 hours </td><td styleCode="Botrule"> 45 mg/kg/day in divided  doses every 12 hours <content styleCode="bold">or </content>40 mg/kg/day in divided doses every 8 hours </td></tr>
<tr><td styleCode="Botrule"> Gonorrhea Acute, uncomplicated
 ano-genital and urethral infections in males and females </td><td styleCode="Botrule"> &#160; </td><td styleCode="Botrule"> 3 grams as
 single oral
 dose </td><td styleCode="Botrule"> <content styleCode="underline">Prepubertal</content> children:
 50 mg/kg amoxicillin, combined with 25 mg/kg probenecid as a single dose.<content styleCode="bold">  </content>
 <content styleCode="bold">NOTE: SINCE PROBENECID IS CONTRAINDICATED IN CHILDREN UNDER 2 YEARS, DO NOT USE THIS REGIMEN IN THESE CASES.</content> </td></tr>
</tbody>
</table><paragraph ID="INV-7d0fd1ee-7275-4a5e-b1dd-7a4300dbc272"><sup>&#8225;</sup> Dosing for infections caused by less susceptible organisms should follow the recommendations for severe infections.</paragraph><paragraph ID="INV-8ed5223d-4361-4b3e-98a5-215c6ddc6cf8"><sup>&#167;</sup> The children&#8217;s dosage is intended for individuals whose weight is less than 40 kg. Children weighing 40 kg or more should be dosed according to the adult recommendations.</paragraph><paragraph ID="INV-f0657f3b-46c9-4635-94bb-009fab0c7115"><sup>&#960;   </sup>Each strength of the suspension of amoxicillin is available as a chewable tablet for use by older children.</paragraph><paragraph ID="INV-ec48da73-ac59-4faa-9686-286d6d57d456">After reconstitution, the required amount of suspension should be placed directly on the child&#8217;s tongue for swallowing. Alternate means of administration are to add the required amount of suspension to formula, milk, fruit juice, water, ginger ale, or cold drinks. These preparations should then be taken immediately. To be certain the child is receiving full dosage, such preparations should be consumed in entirety.</paragraph><paragraph ID="INV-b6fc246e-f617-4e93-a518-b3945df4b81f">All patients with gonorrhea should be evaluated for syphilis. (See <content styleCode="bold">PRECAUTIONS </content>&#8211; <content styleCode="bold">Laboratory Tests</content>.)</paragraph><paragraph ID="INV-210611b8-e458-4bae-b490-b6c05eea8750">Larger doses may be required for stubborn or severe infections.</paragraph><paragraph ID="INV-261969a0-c005-4633-948f-1747968cc25d"><content styleCode="bold">General: </content>It should be recognized that in the treatment of chronic urinary tract infections, frequent bacteriological and clinical appraisals are necessary. Smaller doses than those recommended above should not be used. Even higher doses may be needed at times. In stubborn infections, therapy may be required for several weeks. It may be necessary to continue clinical and/or bacteriological follow-up for several months after cessation of therapy. Except for gonorrhea, treatment should be continued for a minimum of 48 to 72 hours beyond the time that the patient becomes asymptomatic or evidence of bacterial eradication has been obtained. It is recommended that there be at least 10 days&#8217; treatment for any infection caused by <content styleCode="italics">Streptococcus pyogenes</content> to prevent the occurrence of acute rheumatic fever.</paragraph><paragraph ID="INV-e0bd28ee-3093-4626-8b4a-dbe47dd65402"><content styleCode="bold"><content styleCode="italics">H. pylori</content></content><content styleCode="bold"> Eradication to Reduce the Risk of Duodenal Ulcer Recurrence: <content styleCode="italics">Triple Therapy</content></content><content styleCode="italics">:</content> Amoxicillin/clarithromycin/ lansoprazole</paragraph><paragraph ID="INV-dbd04cbf-21fe-4718-ab67-6a13f17c1456">The recommended adult oral dose is 1 gram amoxicillin, 500 mg clarithromycin, and 30 mg lansoprazole, all given twice daily (q12h) for 14 days. (See <content styleCode="bold">INDICATIONS AND USAGE</content>.)</paragraph><paragraph ID="INV-c22813ba-5b03-4a80-b581-d6203590d737"><content styleCode="bold"><content styleCode="italics">Dual Therapy:</content></content>Amoxicillin<content styleCode="italics">/lansoprazole</content></paragraph><paragraph ID="INV-67230f29-e0b7-4e0f-a799-3c6b83068a4f">The recommended adult oral dose is 1 gram amoxicillin and 30 mg lansoprazole, each given three times daily (q8h) for 14 days. (See <content styleCode="bold">INDICATIONS AND USAGE</content>.)</paragraph><paragraph ID="INV-b29348a8-6c1a-408b-b917-96c8d3eba9c1">Please refer to clarithromycin and lansoprazole full prescribing information for <content styleCode="bold">CONTRAINDICATIONS </content>and <content styleCode="bold">WARNINGS</content>, and for information regarding dosing in elderly and renally impaired patients.</paragraph><paragraph ID="INV-c297056c-6df6-4580-837a-b8ccc30b05ec"><content styleCode="bold">Dosing Recommendations for Adults with Impaired Renal Function: </content>Patients with impaired renal function do not generally require a reduction in dose unless the impairment is severe. Severely impaired patients with a glomerular filtration rate of &lt; 30 mL/minute should not receive the 875 mg tablet. Patients with a glomerular filtration rate of 10 to 30 mL/minute should receive 500 mg or 250 mg every 12 hours, depending on the severity of the infection. Patients with a less than 10 mL/minute glomerular filtration rate should receive 500 mg or 250 mg every 24 hours, depending on severity of the infection.</paragraph><paragraph ID="INV-95c16e5e-999a-4340-ac2d-cacbb27989d4">Hemodialysis patients should receive 500 mg or 250 mg every 24 hours, depending on severity of the infection. They should receive an additional dose both during and at the end of dialysis.</paragraph><paragraph ID="INV-9117c76d-77c6-4ea0-be82-8b97b5b6b25e"><content styleCode="bold">There are currently no dosing recommendations for pediatric patients with impaired renal function.</content></paragraph><paragraph ID="INV-295cfe11-5c83-4612-8c1c-2ab8b82fbb15"><content styleCode="bold">Directions for Mixing Oral Suspension: </content>Prepare suspension at time of dispensing as follows: Tap bottle until all powder flows freely. Add approximately 1/3 of the total amount of water for reconstitution (see table below) and shake vigorously to wet powder. Add remainder of the water and again shake vigorously.</paragraph><paragraph ID="INV-0786e005-022d-4201-ae5c-4d9e6d805daa"><content styleCode="bold">200 mg/5 mL</content></paragraph><table ID="INV-cad496a6-0467-482f-bddc-b9725ba0a1a4" frame="void"><col width="304px" />
<col width="316px" />
<tbody>
<tr><td styleCode="Botrule"> Bottle Size </td><td styleCode="Botrule"> <content styleCode="underline">Amount of Water Required for Reconstitution</content> </td></tr>
<tr><td align="center" styleCode="Botrule"> &#160; </td><td align="center" styleCode="Botrule"> &#160; </td></tr>
<tr><td align="center" styleCode="Botrule"> 50 mL </td><td align="center" styleCode="Botrule"> 33 mL </td></tr>
<tr><td align="center" styleCode="Botrule"> 75 mL </td><td align="center" styleCode="Botrule"> 49 mL </td></tr>
<tr><td align="center" styleCode="Botrule"> 100 mL </td><td align="center" styleCode="Botrule"> 66 mL </td></tr>
</tbody>
</table><paragraph ID="INV-be8f347e-9248-4044-a901-672e7f43b5bc">Each teaspoonful (5 mL) will contain 200 mg amoxicillin</paragraph><paragraph ID="INV-9b140b63-7e65-4015-bc25-d6294953b2fa"><content styleCode="bold">400 mg/5 mL</content></paragraph><table ID="INV-b302e33c-08d1-42fa-b158-dbd82fd2f93b" frame="void"><col width="304px" />
<col width="316px" />
<tbody>
<tr><td styleCode="Botrule"> Bottle Size </td><td styleCode="Botrule"> <content styleCode="underline">Amount of Water Required for Reconstitution</content> </td></tr>
<tr><td align="center" styleCode="Botrule"> 50 mL </td><td align="center" styleCode="Botrule"> 33 mL </td></tr>
<tr><td align="center" styleCode="Botrule"> 75 mL </td><td align="center" styleCode="Botrule"> 49 mL </td></tr>
<tr><td align="center" styleCode="Botrule"> 100 mL </td><td align="center" styleCode="Botrule"> 66 mL </td></tr>
</tbody>
</table><paragraph ID="INV-a4d3b8ed-9fe9-477e-9e55-07d242c9c94f">Each teaspoonful (5 mL) will contain 400 mg amoxicillin.</paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
<component>
<section ID="INV-eba60f39-a03e-43f0-a951-ad1db43b0afb">
<id root="C0BA718B-1700-2180-B296-1549C7BF4DAA" />
<code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION" />
<title ID="INV-717150a8-5795-40ec-813c-b882670cdef2">HOW SUPPLIED</title>
<text ID="INV-c4dacfc7-983d-421a-a414-f01333794257"><paragraph ID="INV-f44f562f-cf91-4b92-b020-c76310283fb9"><content styleCode="bold">Amoxicillin Capsules</content><content styleCode="bold">, USP</content><content styleCode="bold">:</content></paragraph><paragraph ID="INV-a2515d44-9cba-4faa-bcde-19c93d67127f">Each capsule contains 250 mg or 500 mg amoxicillin as the trihydrate.</paragraph><paragraph ID="INV-88539cf5-80bc-455a-96c1-6aca6dfbcb35"><content styleCode="bold">250 mg Capsule</content></paragraph><paragraph ID="INV-648a4eff-db90-4a6d-aad4-65c8167b7614">250 mg yellow opaque cap and yellow opaque body, size 2, printed &#8220;RX654&#8221; on both cap and body.</paragraph><paragraph ID="INV-f06be6b3-e76d-406d-956d-4a1a5d65e9f9">NDC 63304-654-20 bottles of 20</paragraph><paragraph ID="INV-895c02a4-f78f-4f64-b953-c61a03fd600a">NDC 63304-654-30 bottles of 30</paragraph><paragraph ID="INV-51272ce0-fd63-4ea9-9d98-67c750c03194">NDC 63304-654-01 bottles of 100</paragraph><paragraph ID="INV-9780847c-9499-41e4-9044-0059663d1a68">NDC 63304-654-05 bottles of 500</paragraph><paragraph ID="INV-9b8ae755-2b80-48ac-a0be-b143155390cc">NDC 63304-654-77 Unit-dose 100s</paragraph><paragraph ID="INV-8e3fec61-730b-414d-96d3-6f8d0d9024ab"><content styleCode="bold">500 mg Capsule</content></paragraph><paragraph ID="INV-1ec4d416-b0d3-4744-95dd-efa3c865ca70">500 mg maroon opaque cap and yellow opaque body, size 0-el, printed &#8220;RX655&#8221; on both cap and body.</paragraph><paragraph ID="INV-dc56f138-f103-406d-8e83-eb0d920daf9d">NDC 63304-762-82	bottles of 12</paragraph><paragraph ID="INV-11ebe3c8-1c47-4f8a-b713-8866890cfdb7">NDC 63304-762-20	bottles of 20</paragraph><paragraph ID="INV-29a6b7ee-3cae-4d5b-a8a1-0e2bd1045c0e">NDC 63304-762-01	bottles of 100</paragraph><paragraph ID="INV-c8d1a8f5-4990-406c-8cd5-394c0c6438b8">NDC 63304-762-13	bottles of 120</paragraph><paragraph ID="INV-0d23ae21-d175-43db-a926-5d60418281c4">NDC 63304-762-05	bottles of 500</paragraph><paragraph ID="INV-d6fddb1b-ecff-422c-a0ff-d04b22f9afd6"><content styleCode="bold">Amoxicillin Tablets</content><content styleCode="bold">, USP</content><content styleCode="bold">:</content></paragraph><paragraph ID="INV-cf245f79-9576-4f25-b8a5-ad1e3ba44f47">Each tablet contains 500 mg or 875 mg amoxicillin as the trihydrate.</paragraph><paragraph ID="INV-3d41aff5-ccc3-489e-9d5a-fb01337321b4"><content styleCode="bold">500 mg Tablet</content></paragraph><paragraph ID="INV-634cd145-b9ed-4f62-b509-0852a7215d3c">500 mg pink colored, film coated, capsule shaped tablets; debossed with &#8220;RX762&#8221; on one side and plain on the other side.</paragraph><paragraph ID="INV-c0346893-e175-4aa7-9e12-6646e022971b">NDC 63304-762-82	bottles of 12</paragraph><paragraph ID="INV-49437ec0-d253-438c-ab41-079f48d87a9b">NDC 63304-762-20	bottles of 20</paragraph><paragraph ID="INV-ee4abe3d-670d-40ad-8906-b11bbf8bbf00">NDC 63304-762-01	bottles of 100</paragraph><paragraph ID="INV-c3cbf08a-9b6d-491c-aca9-eb85fa4eaaaa">NDC 63304-762-13	bottles of 120</paragraph><paragraph ID="INV-64971910-d7f7-46d1-876f-2e764c54ab85">NDC 63304-762-05	bottles of 500</paragraph><paragraph ID="INV-b49abdc2-343c-4af7-8fa3-2b1b901c488e"><content styleCode="bold">875 mg Tablet</content></paragraph><paragraph ID="INV-5e8d6373-28fe-4ec1-a41d-01ee45c90dac">875 mg pink colored, film coated, capsule shaped tablets; debossed with &#8220;RX763&#8221; on one side and scored on reverse side.</paragraph><paragraph ID="INV-0d60adf0-d085-48fb-9b3d-0d1b102c8979">NDC 63304-763-82	bottles of 12</paragraph><paragraph ID="INV-cfddbf78-e814-405d-82be-0bbc553687ff">NDC 63304-763-20	bottles of 20</paragraph><paragraph ID="INV-0cbbb350-23f2-4a62-acc4-47b3a0e23ef2">NDC 63304-763-01	bottles of 100</paragraph><paragraph ID="INV-3056bf0d-09f1-4853-ac84-7985ff1a051d">NDC 63304-763-13	bottles of 120</paragraph><paragraph ID="INV-85f279c0-1175-4846-afae-47a89bd3458a">NDC 63304-763-05	bottles of 500</paragraph><paragraph ID="INV-0ca828c1-85e2-42dc-b030-440770326ce9"><content styleCode="bold">Amoxicillin Chewable Tablets, USP:</content> </paragraph><paragraph ID="INV-afa5dc5a-487c-4212-b909-8f9008607fe6">Each chewable tablet contains 125 mg, 200 mg, 250 mg or 400 mg amoxicillin as the trihydrate.</paragraph><paragraph ID="INV-da638b63-11ab-4530-bcb2-bec8b48d2e41"><content styleCode="bold">125 mg Tablet</content> </paragraph><paragraph ID="INV-eba16428-1128-41f2-9824-d947390d2487">125 mg pink colored, strawberry flavored, oval biconvex tablets, with mottled appearance; debossed with &#8220;RX514&#8221; on one side.</paragraph><paragraph ID="INV-b8ca82a2-c7b1-4606-b3b3-76b455e1122c">NDC 63304-514-01	bottles of 100</paragraph><paragraph ID="INV-1ad2a8ed-bbfc-4b4c-8b70-1d578f81382f">NDC 63304-514-05	bottles of 500</paragraph><paragraph ID="INV-567a1a35-9761-424d-8758-874d3971c381"><content styleCode="bold">200 mg Tablet</content></paragraph><paragraph ID="INV-9dea7660-2141-4348-8225-b2aac681d754">200 mg light pink colored, strawberry flavored, circular, flat faced, beveled edge tablets, with mottled appearance; debossed with &#8220;RX760&#8221; on one side.</paragraph><paragraph ID="INV-27d0e775-a3f3-45a9-b903-8453860da2e3">NDC 63304-760-20	bottles of 20</paragraph><paragraph ID="INV-e52df0c3-980e-4aa7-9e12-17ad46a5dd07">NDC 63304-760-01	bottles of 100</paragraph><paragraph ID="INV-745854b0-c9ef-4a15-aaf5-2095db9e6ef8">NDC 63304-760-05	bottles of 500</paragraph><paragraph ID="INV-c18b9d34-afc2-490f-af01-88f230b1fa0c"><content styleCode="bold">250 mg Tablet</content> </paragraph><paragraph ID="INV-0e54b3af-476d-423c-a7fb-60e6a310a586">250 mg pink colored, strawberry flavored, circular, flat faced, beveled edge tablets, with mottled appearance; debossed with &#8220;RX515&#8221; on one side.</paragraph><paragraph ID="INV-d8196d9f-7a0d-4200-bc36-9e42f7c8f064">NDC 63304-515-30	bottles of 30</paragraph><paragraph ID="INV-9f11dfd6-7de0-4c28-bee7-ad729b43c55c">NDC 63304-515-01	bottles of 100</paragraph><paragraph ID="INV-b9d84d71-1157-420f-a05f-5ef6ca9d2ced">NDC 63304-515-04	bottles of 250</paragraph><paragraph ID="INV-54216479-62de-4585-950d-5a2bf19a5407"><content styleCode="bold">400 mg Tablet</content></paragraph><paragraph ID="INV-677f2954-037b-4bc1-8720-56b0599f88dc">400 mg light pink colored, strawberry flavored, circular, flat faced, beveled edge tablets, with mottled appearance; debossed with &#8220;RX716&#8221; on one side.</paragraph><paragraph ID="INV-296be98c-9505-4db8-9d83-2c17cda3c915">NDC 63304-761-20	bottles of 20</paragraph><paragraph ID="INV-dd133e89-0d3f-45e9-867e-7114b707a4ce">NDC 63304-761-01	bottles of 100</paragraph><paragraph ID="INV-1ec6057f-6943-4712-94ec-3ba18067d9e2">NDC 63304-761-05	bottles of 500</paragraph><paragraph ID="INV-88530d34-87d2-426a-983e-530c66858674"><content styleCode="bold">Amoxicillin For Oral Suspension USP is available in:</content></paragraph><paragraph ID="INV-6aa6207b-59dc-4688-bb04-fae64b0991a1">The 200 mg per 5 mL oral suspension* is off white to light orange granular powder forming a light orange to orange suspension on constitution with water.  The resulting suspension has a characteristic fruity flavor and is available as follows:</paragraph><paragraph ID="INV-10f329e3-bf4f-44ba-beee-fe43ae977231">NDC 63304-969-03	50 mL bottles</paragraph><paragraph ID="INV-ff267102-1987-4135-b7ed-ac6d8df61d9a">NDC 63304-969-01 	75 mL bottles</paragraph><paragraph ID="INV-785931f7-9391-43e4-b158-3cb751580ef5">NDC 63304-969-04	100 mL bottles</paragraph><paragraph ID="INV-a7946a1e-e59c-43f4-9d8d-ccd1bb92895c">The 400 mg per 5 mL oral suspension* is off white to light orange granular powder forming a light orange to orange suspension* on constitution with water.  The resulting suspension has a characteristic fruity flavor and is available as follows:</paragraph><paragraph ID="INV-03b08587-6ebc-4b45-84e5-2b8e3f602a9c">NDC 63304-970-03 	50 mL bottle </paragraph><paragraph ID="INV-fd30c999-aa77-46a4-9d51-30e400719adb">NDC 63304-970-01	75 mL bottle</paragraph><paragraph ID="INV-b1788dca-3a4e-4128-9f30-16f89e8196d2">NDC 63304-970-04	100 mL bottle</paragraph><paragraph ID="INV-665925ab-863e-4f2a-a6f8-d84a3f6d21e9">*SHAKE ORAL SUSPENSION WELL BEFORE USING. Keep bottle tightly closed. Any unused portion of the reconstituted suspension must be discarded after 14 days. Refrigeration preferable, but not required.</paragraph><paragraph ID="INV-81f99456-801d-4d46-9717-0f1f51091984">Dispense in a tight container.</paragraph><paragraph ID="INV-84d1222c-25d4-4c2e-9e3b-c2f812f38452">Store amoxicillin capsules 250 mg and 500 mg, &#160;amoxicillin tablets 500 mg and 875 mg, amoxicillin chewable tablets 125 mg, 200 mg, 250 mg and 400 mg and amoxicillin unreconstituted powder 200 mg/5 mL and 400 mg/5 mL at controlled room temperature 15&#176; &#8211; 30&#176; C (59&#176; &#8211; 86&#176; F) (see USP). </paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
<component>
<section ID="INV-f7f10409-c6b6-490e-bc48-191a8a0da5a0">
<id root="21D9AEBF-81EC-C77B-FCEF-E5BEC5CE912E" />
<code code="34092-7" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL STUDIES SECTION" />
<title ID="INV-3645421f-637f-4742-b506-ed933b64bbce">CLINICAL STUDIES</title>
<text ID="INV-1f2ada7c-c373-4056-aaab-176d18f78741"><paragraph ID="INV-9401aa6e-9462-43c8-8331-ff04a077c8e7"><content styleCode="bold">H. <content styleCode="italics">Pylori</content> Eradication to Reduce the Risk of Duodenal Ulcer</content> <content styleCode="bold">Recurrence:</content> Randomized, double-blind clinical studies performed in the United States in patients with <content styleCode="italics">H. pylori</content> and duodenal ulcer disease (defined as an active ulcer or history of an ulcer within 1 year) evaluated the efficacy of lansoprazole in combination with amoxicillin capsules and clarithromycin tablets as triple 14 day therapy, or in combination with amoxicillin capsules as dual 14 day therapy, for the eradication of <content styleCode="italics">H. pylori</content>. Based on the results of these studies, the safety and efficacy of 2 different eradication regimens were established:</paragraph><paragraph ID="INV-785fea3f-eff3-4b82-a9d7-9ab1a0f0bfe4"><content styleCode="bold"><content styleCode="italics">Triple Therapy</content></content><content styleCode="italics">:</content> Amoxicillin 1 gram twice daily/clarithromycin 500 mg twice daily/lansoprazole 30 mg twice daily.</paragraph><paragraph ID="INV-28dc4c7a-9d51-4236-bd32-a5a7b66a6dfb"><content styleCode="italics"><content styleCode="bold">Dual Therapy:</content></content> Amoxicillin 1 gram three times daily/ lansoprazole 30 mg three times daily.</paragraph><paragraph ID="INV-853af8d3-74ea-46a1-8ccb-a2043207662f">All treatments were for 14 days. <content styleCode="italics">H. pylori</content> eradication was defined as 2 negative tests (culture and histology) at 4 to 6 weeks following the end of treatment.</paragraph><paragraph ID="INV-5e279551-901a-4361-91b8-837310445466">Triple therapy was shown to be more effective than all possible dual therapy combinations. Dual therapy was shown to be more effective than both monotherapies. Eradication of <content styleCode="italics">H. pylori</content> has been shown to reduce the risk of duodenal ulcer recurrence.</paragraph><paragraph ID="INV-cf2d5eab-f75a-4742-8e47-38f0549efb7a"><content styleCode="bold"><content styleCode="italics">H. pylori </content></content><content styleCode="bold">Eradication Rates &#8211; Triple Therapy (amoxicillin/clarithromycin/lansoprazole) Percent of Patients Cured [95% Confidence Interval] </content><content styleCode="bold">(Number of Patients)</content></paragraph><table ID="INV-f69eecb9-ef30-4cdb-8069-a248e8ce4403" frame="void"><col width="108px" />
<col width="264px" />
<col width="244px" />
<tbody>
<tr><td rowspan="2" styleCode="Botrule"> Study </td><td align="center" styleCode="Botrule"> Triple Therapy </td><td align="center" styleCode="Botrule"> Triple Therapy </td></tr>
<tr><td align="center" styleCode="Botrule"> <content styleCode="bold">Evaluable Analysis<sup>&#8224;</sup></content> </td><td align="center" styleCode="Botrule"> <content styleCode="bold">Intent-to-Treat Analysis<sup>&#8225;</sup></content> </td></tr>
<tr><td align="center" styleCode="Botrule"> Study 1 </td><td align="center" styleCode="Botrule"> 92<sup>&#167;</sup> [80 to 97.7]  (n = 48) </td><td align="center" styleCode="Botrule"> 86<sup>&#167;</sup> [73.3&#8211;93.5] (n = 55) </td></tr>
<tr><td align="center" styleCode="Botrule"> Study 2 </td><td align="center" styleCode="Botrule"> 86<sup>ll</sup> [75.7&#8211;93.6] (n = 66) </td><td align="center" styleCode="Botrule"> 83<sup>ll</sup> [72 to 90.8] (n = 70) </td></tr>
</tbody>
</table><paragraph ID="INV-3c76e909-47ca-466a-9a44-035db2861382"><sup>&#8224;</sup> This analysis was based on evaluable patients with confirmed duodenal ulcer (active or within 1 year) and <content styleCode="italics">H. pylori</content> infection at baseline defined as at least 2 of 3 positive endoscopic tests from CLOtest<sup>&#174;</sup>, (Delta West Ltd., Bentley, Australia), histology, and/or culture. Patients were included in the analysis if they completed the study. Additionally, if patients dropped out of the study due to an adverse event related to the study drug, they were included in the analysis as failures of therapy.</paragraph><paragraph ID="INV-4f34116d-1f48-43d7-922b-4f0fdf7232a7"><sup>&#8225;</sup>   Patients were included in the analysis if they had documented <content styleCode="italics">H. pylori</content> infection at baseline as defined above and had a confirmed duodenal ulcer (active or within 1 year). All dropouts were included as failures of therapy.</paragraph><paragraph ID="INV-3994face-2d21-4e03-865a-a24d18423f43"><sup>&#167;</sup> (p&lt; 0.05) versus lansoprazole/amoxicillin and lansoprazole/clarithromycin dual therapy.</paragraph><paragraph ID="INV-0cb10d4e-e01c-4acb-83db-a413698c4f2c"><sup>ll</sup> (p&lt; 0.05) versus clarithromycin/amoxicillin dual therapy.</paragraph><paragraph ID="INV-01eb51fd-ddb4-404a-8cb5-2cfaf76087c2"><content styleCode="bold"><content styleCode="italics">H. pylori </content></content><content styleCode="bold">Eradication Rates &#8211; Dual Therapy (amoxicillin/lansoprazole) Percent of Patients Cured [95% Confidence Interval] </content><content styleCode="bold">(Number of Patients)</content></paragraph><table ID="INV-d38ff63a-0571-40cf-973b-2180fe733e49" frame="void"><col width="100px" />
<col width="256px" />
<col width="264px" />
<tbody>
<tr><td rowspan="2" styleCode="Botrule"> Study </td><td align="center" styleCode="Botrule">  Dual Therapy </td><td align="center" styleCode="Botrule">  Dual Therapy </td></tr>
<tr><td align="center" styleCode="Botrule"> <content styleCode="bold">Evaluable Analysis<sup>&#182;</sup></content> </td><td align="center" styleCode="Botrule"> <content styleCode="bold">Intent-to-Treat Analysis<sup>&#8224;&#8224;</sup></content> </td></tr>
<tr><td align="center" styleCode="Botrule"> Study 1 </td><td align="center" styleCode="Botrule"> 77<sup>&#8225;&#8225;</sup> [62.5&#8211;87.2] (n=51) </td><td align="center" styleCode="Botrule"> 70<sup>&#8225;&#8225;</sup> [56.8&#8211;81.2] (n=60) </td></tr>
<tr><td align="center" styleCode="Botrule"> Study 2 </td><td align="center" styleCode="Botrule"> 66<sup>&#167;&#167;</sup>[51.9&#8211;77.5] (n=58) </td><td align="center" styleCode="Botrule"> 61<sup>&#167;&#167;</sup>[48.5&#8211;72.9] (n=67) </td></tr>
</tbody>
</table><paragraph ID="INV-f98e3ccb-8bbd-4144-8591-17f2e36cd0d5"><sup>&#182;</sup> This analysis was based on evaluable patients with confirmed duodenal ulcer (active or within 1 year) and <content styleCode="italics">H. pylori</content> infection at baseline defined as at least 2 of 3 positive endoscopic tests from CLOtest<sup>&#174;</sup>, histology, and/or culture. Patients were included in the analysis if they completed the study. Additionally, if patients dropped out of the study due to an adverse event related to the study drug, they were included in the analysis as failures of therapy.</paragraph><paragraph ID="INV-da41caf4-d3a3-466d-becd-9db75302ed17"><sup>&#8224;&#8224;</sup> Patients were included in the analysis if they had documented <content styleCode="italics">H. pylori</content> infection at baseline as defined above and had a confirmed duodenal ulcer (active or within 1 year). All dropouts were included as failures of therapy.</paragraph><paragraph ID="INV-a4056118-8452-4477-967c-43f08549a179"><sup>&#8225;&#8225;</sup> (<content styleCode="italics">p </content>&lt; 0.05) versus lansoprazole alone.</paragraph><paragraph ID="INV-9ee59a28-6d4c-477f-921d-62182598d428"><sup>&#167;&#167; </sup>(<content styleCode="italics">p </content>&lt; 0.05) versus lansoprazole alone or amoxicillin alone.</paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
<component>
<section ID="INV-d60a1f92-88c9-4e11-903b-85de343a06e2">
<id root="30385467-A428-2DE1-DA91-5F5ACE0C2754" />
<code code="34093-5" codeSystem="2.16.840.1.113883.6.1" displayName="REFERENCES SECTION" />
<title ID="INV-b61ba194-1ca5-4f98-a026-fa3e926686b5">REFERENCES</title>
<text ID="INV-7b3c1db0-0fe6-415a-803e-88cff35e33fe"><list listType="ordered" styleCode="Arabic"><item>National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fourth Edition; Approved Standard. NCCLS Document M7-A4, Vol. 17, No. 2. NCCLS, Wayne, PA, January 1997.</item><item>National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests - Sixth Edition; Approved Standard. NCCLS Document M2-A6, Vol. 17, No. 1. NCCLS, Wayne, PA, January 1997.</item><item>Swanson-Biearman B, Dean BS, Lopez G, Krenzelok EP. The effects of penicillin and cephalosporin ingestions in children less than six years of age. Vet Hum Toxicol. 1988; 30:66-67.</item></list><paragraph ID="INV-61886ec3-de11-4136-b81e-383ae2b66659">CLINITEST is a registered trademark of Miles, Inc.</paragraph><paragraph ID="INV-8e3d6b6c-d2e1-49fc-b32f-3d642cfa01ad">CLINISTIX is a registered trademark of Bayer Corporation.</paragraph><paragraph ID="INV-7612176b-892c-47f7-9012-4f2e7b6e81eb">CLOtest is a registered trademark of Kimberly-Clark Corporation.</paragraph><paragraph ID="INV-ecc8ad9e-96e0-4e6b-94b9-12443effa44f">Manufactured for: </paragraph><paragraph ID="INV-40a47a9e-f443-4d36-aab6-47696aff9e3e">Ranbaxy Laboratories, Inc.</paragraph><paragraph ID="INV-314db2ef-ff65-4cb9-979c-e8c6036e5d24">Jacksonville, FL  32257 USA </paragraph><paragraph ID="INV-08345bbb-58c7-46b4-be52-65bab016b792">by: Ranbaxy  Laboratories Limited </paragraph><paragraph ID="INV-97347f9e-79e7-4a0b-b346-fc218357673b">New Delhi &#8722; 110 019, India</paragraph><paragraph ID="INV-1a0faebf-93af-491d-8eb4-84e7845b64f7">April 2008</paragraph></text>
<effectiveTime value="20080519" />
</section>
</component>
</structuredBody>
</component>
</document>
